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Abstract 
Stroke and traumatic brain injury are among the leading causes of death in the world. Until now, 
there are no effective treatments available. Current pharmaceutical treatments have limited 
benefits to repair the damaged tissue. Brain tissue engineering is a promising strategy to help 
brain regeneration after the damage induced by stroke or traumatic brain injury. In this thesis, 
our work focused on designing and evaluating appropriate silk fibroin-based hydrogels combined 
with stem cells therapy for brain tissue regeneration. 
The work initially started from looking for appropriate silk fibroin-based hydrogel substrates 
which can support the viability and neural differentiation of pluripotent cells. Mouse embryonic 
stem cells (mESC) were used as a model. Different processing procedures of silk fibroin-based 
hydrogel substrates were prepared by chemical genipin crosslinking and physical sonication 
crosslinking. The viability and neural differentiation of pluripotent cells on these hydrogel 
substrates were evaluated, using tissue culture plates (TCP) as control. Different crosslinking 
processes were found to modulate the neural differentiation of pluripotent cells. Chemical 
genipin crosslinked hydrogel substrates could inhibit the neural differentiation of mESC 
compared to control TCP, while the physical sonication crosslinked hydrogel substrates could 
support the neural differentiation as TCP. 
According to the results obtained in the first stage, the physically sonication-crosslinked 3D silk 
fibroin hydrogel was produced to encapsulate human neural stem cells (hNSC). In order to 
improve the hNSC attachment and neuronal differentiation, the isoleucine-lysine-valine-alanine-
valine (IKVAV) peptide derived from laminin was covalently conjugated to the silk fibroin. The 
viability and neural differentiation of hNSC were evaluated in the unmodified and IKVAV 
peptide modified silk fibroin hydrogels. We found that the IKVAV peptide modified silk fibroin 
hydrogel could increase the viability, proliferation and neuronal differentiation of hNSC. 
Furthermore, the angiogenesis potential of sonication-induced 3D silk fibroin unmodified and 
modified with IKVAV and a scramble peptide VVIAK (as control) were evaluated in a human 
outgrowth endothelial cells (OEC) mono-culture system and a co-culture system in which OEC 
were cultured with human bone marrow mesenchymal stem cells (BM-MSC). Both the silk 
fibroin unmodified and modified with IKVAV peptide could not induce angiogenesis in the 
mono-culture system under the VEGF condition. However, in the co-culture system, we found 
that unmodified, IKVAV-modified and VVIAK-modified silk fibroin hydrogels all could support 
angiogenesis. Furthermore, there were no significant differences among unmodified, IKVAV 
modified and VVIAK modified silk fibroin hydrogels influencing on angiogenesis structure and 
gene expression related to angiogenesis. 
The thesis will introduce the detailed work in three different chapters (from chapter 3 to chapter 
5) respectively. 
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Chapter 2: General introduction 
2.1 Tissue engineering and regenerative medicine 
In adult human body, tissues and organs could be damaged and their functions could be lost by a 
wide range of diseases and injuries which include trauma, degenerative diseases, inflammation, 
or other conditions. The self-repair ability of the body is usually limited without medical 
intervention. Many damaged tissues can not be regenerated by themselves, such as central 
nervous system. Moreover, the repair process might involve producing scar tissues instead of 
restoring the normal structure and function of tissues (1, 2).  
 
Fig 2.1 Principle of tissue engineering.  
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Therefore, to induce regeneration of damaged tissue, the concept of tissue engineering occurred.  
In 1993, Langer and Vacanti provided the definition of tissue engineering as “an interdisciplinary 
field that applies the principles of engineering and life sciences toward the development of 
biological substitutes that restore, maintain, or improve tissue function or a whole organ” (3). 
Then in 2006, David F. Williams defined tissue engineering as “Tissue engineering is the 
creation of a new tissue for the therapeutic reconstruction of the human body, by the deliberate 
and controlled stimulation of selected target cells, through a systematic combination of 
molecular and  mechanical signals ” (2) (Fig 2.1). 
2.1.1 Key elements  
To regenerate the damaged tissues, there are two main strategies in tissue engineering (Fig 2.1). 
The first approach is named in situ regeneration, and involves the design of an inductive scaffold 
(with or without growth factor/drug delivery system) which should interact with the implantation 
environment, guiding cells from surrounding tissue to adhere and migrate in the scaffold and 
trigger new tissues formation. This approach relies on the development of a target-specific 
scaffold system that can effectively mobilize host stem/progenitor cells to target tissues. (4) In 
situ tissue regeneration has been applied to various therapeutic applications. For example, the 
scaffold made by calcium phosphate, calcium sulfate and hydroxyapatite were widely used for in 
situ bone regeneration (4). Scaffolds consisting of biodegradable PLGA polymer were 
incorporated with plasma and hyaluronic acid, then were implanted into micro-fractured cartilage 
tissue (5). Besides, this in situ regeneration concept was also translated to regeneration of other 
tissues, such as skeletal muscle, brain, cardiovascular, spine and skin (4). However, when the 
damaged tissues have poor regenerative ability (such as brain and myocardium) and the defect 
size is critical, the first approach is limited because it relies on the body’s own regenerating 
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capacity. Therefore, a complex cells-based tissue engineering strategy has emerged as a 
promising approach to overcome these limitations. In this approach, to specifically guide tissue 
regeneration and stimulate the specific target tissue cell population, the scaffold can be cultured 
in the hybrid-system in vitro to synthesize new tissue or can be implanted in vivo. These 
scaffolds not only induce surrounding cells growth but also serve as templates for the implanted 
cells to attach, grow, migrate or differentiate. The desired tissue regeneration can be developed 
via proliferation and differentiation of the host cells and transplanted cells. This strategy has 
been applied in tissues such as bone (6), cartilage (7), liver (8), blood vessels (9), and nerve 
(10).These two approaches could be utilized separately depending on the application and could 
also be combined as a promising strategy in tissue engineering. The three components: scaffold, 
cells and signals are usually described as a tissue engineering triad (Fig 2.2) (11).  
 
Fig 2.2 Key elements in Tissue engineering and regenerative medicine 
2.1.1.1 Scaffold 
Scaffold is a basic three-dimension (3D) bioactive framework for cell activity and subsequent 
tissue regeneration. Human tissues reside in the extracellular matrix (ECM), which are an 
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instructive physical environment and a structure supporting for cells in the tissues to attach, grow 
and migrate (12). Therefore, the natural ECM represents an appealing model to design bioactive 
scaffolds (13). Regardless of different tissue engineering applications, the scaffold must be 
biocompatible, the cells in the implanted environment or the pre-seeded cells should be able to 
adhere, proliferate and migrate in the scaffold before producing new matrix. After implantation, 
the inflammatory responses should be guided to the transition of tissue repair. Then, the scaffold 
should have porous architecture, which allows cells proliferation and migration, nutrients and 
oxygen diffusion, as well as new capillary formation. Scaffolds should also have the bioactivity 
to interact with host tissue facilitating and regulating the cell activities. They also need to be 
endowed with biological cues to influence cell adhesion, proliferation and/or stem cells 
differentiation. Upon the implantation site, the scaffold must be controlled biodegradable so that 
the cells could produce their own ECM that can eventually replace the implantation scaffolds 
(14). Depending on the different tissue regeneration application, the mechanical properties 
should be varied when designing specific scaffolds to match the host tissue. Different tissue cell 
types like fibroblasts, myocytes, neurons, and other cell types reside in the ECM of different 
stiffness. These cells can just sense the matrix whose stiffness are similar to their resident tissues 
(15). Furthermore, the stiffness of scaffolds can also affect the stem cells differentiation to 
specific lineages, consistent with the resident elasticity of differentiated cell types (16).  
Biomaterials are the starting point to fabricate artificial 3D frameworks referred as scaffolds, 
matrices, or constructs (17). At the conference of European Society for Biomaterials (ESB) in 
1976, the biomaterial was firstly defined as “a nonviable material used in a medical device, 
intended to interact with biological systems”. Then, the definition is evolved to “a material 
intended to interface with biological systems to evaluate, treat, augment or replace any tissue, 
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organ or function of the body” (14). Until now, biomaterials have been widely used as implants 
in the form of sutures, bone plates, joint replacements, ligaments, vascular grafts, heart valves, 
intraocular lenses, dental implants, and medical devices like pacemakers, biosensors, and so forth 
(17, 18).  
Polymers, synthetic and naturally-derived, are widely used as biomaterials to fabricate scaffolds 
for tissue engineering. Natural polymers and synthetic polymers are the main types used in 
designing scaffolds. Both of them have advantages and disadvantages in the application of tissue 
engineering.  
Synthetic polymers are widely used in tissue engineering because they can be tailored in a range 
of properties (such as strength, flexibility and degradation) compared to natural polymers. 
Besides, they are much cheaper than natural polymers and can be widely produced in uniform 
quantities and have a long shelf time. However, their biocompatibility and biodegradability are 
the disadvantages, limiting their potential use in the clinical side. (17). Many synthetic polymers 
such as PLA (19), PCL(20), PLGA (21) PEVA (22) have been widely used in tissue engineering.  
Natural polymers are derived from natural living creature sources. Unlike synthetic polymers, 
natural polymers are biologically active because of the inherent bio-recognition. They are able to 
support excellent cell adhesion and growth. Furthermore, most of them are biodegradable and 
therefore allow host cells, or pre-seeded cells, to produce their own ECM (14). Natural-derived 
polymers are usually classified into three groups (23): 
(i) Protein-origin polymers (such as collagen, gelatin, fibrinogen, silk, elastin, keratin, actin, 
myosin and so on) can mimic aspects of natural protein in ECM and thus have the potential to 
guide the attachment, growth, migration and differentiation of cells in tissue regeneration and 
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wound healing, as well as for stabilization of encapsulated and transplanted cells. Protein-origin 
polymers structures are composed by distinct amino acids linked by amide (or peptide) bonds. 
Amino acids are the building blocks of polypeptides and proteins, which consist of a central 
carbon linked to an amine group, a carboxyl group, a hydrogen atom, and a side chain (23). For 
examples, collagen is a naturally occurring matrix polymer, which is regarded as an ideal 
scaffold or matrix for tissue engineering (24). It is the major protein component of the 
extracellular matrix, providing support to connective tissues such as skin, tendons, bones, 
cartilage, blood vessels, and ligaments (25). Gelatin is a denatured, biodegradable protein 
obtained by acid and alkaline processing of collagen (26), and is commonly used for 
pharmaceutical and medical applications because of its biodegradability and biocompatibility in 
physiological environments (27).  
(ii) Polysaccharides are a class of biopolymers constituted by sugars as monomers (28).  They 
can be obtained from different sources such as microbial, animal and vegetal (29) 
Polysaccharides are non-toxic, which show interaction with living cells and usually have low 
costs in comparison with others biopolymers such as collagen (30) Furthermore, polysaccharides 
show good hemocompatibility properties because of the chemical similarities with heparin. 
Different polysaccharides such as aginate, chitosan, hyaluronan, Chondroitin sulphate cellulose, 
amylose, dextran, chitin, carrageenans, glycosaminoglycans, and so on have been widely utilized 
as scaffold materials in tissue engineering applications as well as carriers for drug delivery 
systems. 
(iii) Bacterially synthesized polyhydroxyalkanoates (PHAs) have attracted much attention 
because they can be produced from a variety of renewable resources, and are truly biodegradable 
and highly biocompatible thermoplastic materials (31) 
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Although natural origin materials also present some drawbacks such as limited processability, 
the difficulties in  controlling the mechanical properties and the variability from batch to batch, 
their advantages clearly surplus the drawbacks and they are still very attractive candidates for 
biomedical applications because of their biocompatibility, degradability, low cost and 
availability, similarity with the ECM and intrinsic cellular interaction for tissue engineering 
applications. Furthermore, in order to overcome the disadvantages of synthetic or natural 
polymers in tissue engineering application, composite materials by blending both materials have 
arisen growing interests to improve the scaffold properties, controlled degradation and 
biocompatibility (17).  
2.1.1.2 Cell sources 
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Fig 2.3 Stem cells resources for tissue engineering and regenerative medicine: Embryonic stem cells(a), Induced 
pluripotent cells(b) and Adult stem cells(c) (32). 
 
In the second strategy of tissue engineering that combines cells and scaffolds, the sources of cells 
are important. Some successes have come from the use of autologous cells, taken from the 
patient, and used in conjunction with scaffolds to produce tissues for re-implantation. However, 
this strategy has limitations, because of the invasive nature of cell collection and the potential for 
cells to be in a diseased state (11). Therefore, in such situations, stem cells are considered as an 
important alternative cell sources because of their ability to self-renew and to produce 
specialized progeny. Embryonic stem cells, adult stem cells and induced pluripotent stem cells 
are obtained from three different sources and have different advantages and limitations (32) (Fig 
2.3). 
Embryonic stem cells (ESCs) are pluripotent cells, which can proliferate in self-renewal stage 
and can be differentiated into many specialized cell types (33). Human embryonic stem cells 
(hESCs), firstly derived by Thomson in 1998 (34), aroused great interest in tissue engineering 
and regenerative medicine because of their multi-ability to differentiate into any adult tissue cell 
type (35). However, hESCs are restricted to their clinical application due to the ethical problems 
and regulations. Furthermore, when implanted in an animal model, hESCs can possibly give rise 
to teratoma, tumor-like formations containing tissues belonging to all three germ layers (36). In 
parallel, stem cells derived from adult tissues (adult stem cells) have also a promising potential in 
tissue engineering with considerable advantages. They are immunocompatible and are not 
associated with ethical concerns. However, challenges remain related to optimization of isolation 
techniques that avoid contamination, permanently maintain the desired cell types following 
differentiation, and produce a large number of cells that are adequate for the construction of a 
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tissue or organ (37). Adult stem cells  have been isolated from different tissues such as bone 
marrow (38), adipose tissue, peripheral blood, amniotic fluid or umbilical cord blood (39). 
Finally, induced pluripotent stem cells have all of the properties of embryonic stem cells, 
overcoming the problem of immune tolerance and the ethical issues faced by the use of human 
embryonic stem cells. However, the currently available methods to reprogram somatic cells and 
to generate induced pluripotent stem cells are extremely slow and inefficient (32). 
2.1.1.3 Signaling molecules delivery 
Growth factors are soluble-secreted signaling polypeptides capable of instructing specific 
cellular responses in a biological environment (40). They could trigger a wide range of cell 
responses, which include cell survival, cell migration, proliferation or differentiation of a specific 
subset of cells (41). Growth factor could bind to specific transmembrane receptors of the target 
cells. Then the growth factor-binding signals are conducted to the cell nucleus, which results in a 
complex array of events involving cytoskeleton protein phosphorylation, ion fluxes, changes in 
metabolism and gene expression, protein synthesis and ultimately an integrated biological 
response (42). The specific growth factor can be chemically conjugated and/or physically 
encapsulated in the scaffold to release in the target tissue or they can be added in the culture 
conditions in vitro. Many growth factors have been applied in tissue engineering. For example, 
vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) and angiopoietin-1 
(Ang-1) are required for the angiogenesis of pre-existing blood vessels, as well as for promoting 
the proliferation and migration of new cells to form new immature vessels (43), bone 
morphogenetic proteins-2 (BMP-2) and transforming growth factor-β3 (TGF-β3) in alginate 
hydrogels, VEGF and BMP-2 from gelatin microparticles have been reported to enhance healing 
effects (44, 45).  
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Consequently, tissue engineering is a multidisciplinary field that involves the principles and 
methods of engineering, life science and clinics. Successful strategies in tissue engineering 
require the optimization of the combination of scaffolds, cells and growth factors which is still a 
complex process. Even though there are still many challenges in developing the regenerated 
tissue, results now are still promising. 
 
2.2 Brain tissue engineering 
The nervous system is composed of peripheral nervous system (PNS) and central nervous system 
(CNS). In contrast to the PNS, the CNS and especially the adult brain possess a very limited 
ability to regenerate after damages.  
2.2.1 Brain injuries 
Many physical injuries and neurological disorders can result in brain damage: (i) stroke, which 
can be categorized as hemorrhagic, ischemic, or embolic in origin, is the third leading cause of 
death in the world. (46). Ischemic stroke accounts for 80% of all brain strokes which is the death 
of an area of brain tissue (cerebral infarction) resulting from an inadequate supply of blood and 
oxygen due to the blockage of an artery. (ii) Traumatic brain injury (TBI) is another major cause 
of brain health problems, more than 1.4 million new cases are reported annually in the USA. 
Like stroke, TBI causes severe disability and there is still no effective clinical treatment available 
worldwide to repair the damaged tissues (47). Besides, neurodegenerative diseases are also 
consistently increasing, like Parkinson’s disease. All these damages, often result in the loss of 
neuronal cell bodies and axons (46), which also involving the recruitment and activation of 
astrocytes, macrophages, and microglia and ultimately forming a glial scar, a physical and 
chemical barrier for regeneration (48, 49). Most treatments currently use pharmacological agents 
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aiming to reduce the sequelae of injury in the acute phase and to enhance the remaining brain 
tissue function during the chronic stage of the injury process. This occurs, however, without 
eliciting tissue regeneration (50).  
Therefore, brain tissue engineering is a promising strategy to repair the injured brain tissue. 
Scaffolds act as artificial environments to support the long-term growth of endogenous and 
therapeutic cells pre-seeded in the scaffolds, facilitating cell regeneration but also preventing 
further damage to adjacent tissues. Combination of cell therapy in brain tissue engineering is also 
a main research area to replace the lost neural cells.  
2.2.2 Neural stem cells  
One promising approach is the use of stem cells, especially neural stem cells (NSCs) for 
damaged brain tissue regeneration. NSCs are present both in the developing and adult brain. 
They can self-renew and generate both neurons and glial cells in the developing brain and 
therefore are potential cell sources for regeneration of the adult brain (51). At early embryonic 
stages, NSCs exist as neuroepithelial stem cells in the embryonic neural tube. In this stage, NSCs 
expand their population by symmetric cell divisions, before they start to produce neurons. 
Subsequently, the neuronal lineages are generated by NSCs through asymmetric cell divisions in 
the germinal ventricular zone (VZ). After this major neurogenic period, NSCs acquire gliogenic 
competency and produce glial progenitor cells, which proliferate mostly in a second germinal 
zone, the subventricular zone (SVZ). By the postnatal stage, the radial glial have transformed 
into astrocytes and the VZ has disappeared, but some portions of the SVZ remain into adulthood, 
to become sites of adult neurogenesis. Adult endogenous NSCs can be found in the two principal 
adult neurogenic regions, the hippocampus and the SVZ, indicating that possible regenerative 
capabilities are preserved in the adult mammalian brain (51). However, although endogenous 
 12 
 
NSCs are presented in the adult brain, the mechanism that regulates their self-renewal and 
differentiation after injury is still poorly understood. Furthermore, the brain regions to which 
their progeny migrate in order to differentiate remain unresolved. 
Thus, besides the activation of endogenous NSCs, NSCs transplantation is a more promising 
strategy to regenerate the damaged brain tissue. NSCs can be derived from many sources, 
including embryonic stem cells, fetal stem cells, adult stem cells and induced pluripotent stem 
cells (46). NSCs have been isolated from many regions of the embryonic nervous system (52) 
and adult brain tissue (53). In the beginning stages of NSCs transplantation, cells were directly 
injected into the lesion sites, which resulted in low cell viability of the transplanted cells and the 
further damage to the host tissue (46). Furthermore, NSCs transplanted into the brain in the 
absence of a supporting niche largely differentiated into glial cells (54).  
Therefore, to support the functions of NSCs, an important niche, the NSCs microenvironment 
must be provided. Adult NSCs microenvironment in mammalian,  usually contains resident stem 
cells, vessels, stromal cells, and a specialized ECM (Fig 2.4) (55). Although some signaling 
molecules can control the functions of NSCs, ECM is a long-term structure niche to maintain the 
functions of NSCs. The structure, mechanical and chemical properties, as well as the signaling 
molecules in ECM could all contribute to controlling the behavior and differentiation fate of 
NSCs. Brain tissue engineering aims at creating such a specialized scaffold to mimic the 
microenvironment ECM for NSCs and help damaged brain tissue regeneration. More specifically, 
this scaffold should enhance the viability of transplanted NSCs and control their differentiation 
fate. 
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Fig 2.4: NSCs niche in the mammalian SVZ: ASC, astrocyte; EPC, ependymal cell; NBs, neuroblasts; NSC, neural 
stem cell; (55) 
 
2.2.3 Hydrogel design  
The natural brain is a very unique tissue, as it has unusual ECM components such as lecticans, 
proteoglycans, hyaluronic acid and tenascin family proteins (56), as well as its soft physical 
properties. Therefore, although many different kinds of scaffolds are used in brain tissue 
engineering such as nanofibers (57), much of the research efforts focused on the development of 
hydrogels (58). Hydrogels are high water content polymers, which can be produced by both 
natural and synthetic materials such as collagen (59), hyaluronic acid (60), alginate (61), chitosan 
(62) and Polyethylene glycol (PEG) (63). Easy diffusion of nutrients, oxygen and cellular 
metabolites are permitted in hydrogels (64). Furthermore, hydrogels are mainly used, as they 
display similar mechanical properties (such as rheology behavior)  to those of the central nervous 
system ECM (46). Many different types of hydrogel have been fabricated and evaluated for brain 
application by mimicking the biochemical and mechanical properties of brain. Synthetic 
hydrogels such as poly[N-2-(hydroxypropyl) methacrylamide] (PHPMA), Polyethylene glycol 
(PEG) and so on. PEG has many excellent qualities for this application, including being highly 
hydrophilic, biocompatible, non-immunogenic, and neuroprotective. However, due to the 
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polyether backbone, it is non-degradable in the body (65).  Biological derived hydrogels such 
collagen, hyaluronic acid (HA) chitosan, agarose, alginate, methyl cellulose, xyloglucan, 
Matrigel, fibrin, PolySia-based hydrogels, peptide hydrogels are widely used in the CNS 
regeneration (46). These natural polymers have biocompatibility, intrinsic biological activity, as 
well as degradability, by the naturally occurring enzymes. To better mimic the brain tissue ECM 
and control the differentiation fate of NSC, many aspects of the hydrogel design should be 
considered.   
(i) Hydrogel stiffness 
In the human body, different kinds of cells reside in tissues of different stiffness ranging from 
soft tissue to stiff tissue, like neurons in the soft brain tissue while osteoblasts in the hard bone 
tissue (Fig 2.5). Meanwhile, stem cells differentiation to specific lineages is also greatly effect by 
the specific microenvironment. Soft matrices that mimic brain are neurogenic, stiffer matrices 
that mimic muscle are myogenic, and comparatively rigid matrices that mimic collagenous bone 
improve osteogenic responses (66). For example, on photopolymerizable methacrylamide 
chitosan hydrogel surfaces of different stiffness, it had been demonstrated that neuronal 
differentiation was favored on the softest surfaces with Young’s elastic modulus less that 1 kPa 
which highlights the importance of mechanical properties to the success of scaffolds designed to 
engineer the NSCs differentiation fate (62). 
 
Fig 2.5 Solid tissues exhibit a range of stiffness, as measured by the elastic modulus, E. (16) 
(ii) Hydrogel structure 
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In stem cells transplantation strategy, hydrogels are usually used to embed cells. Therefore, it is 
critical to create 3D porous hydrogels to facilitate the mass transport of oxygen, nutrients and 
waste. The porous structure is also important for the cells proliferation and migration. Porous 
hydrogels could be produced and different methods could enhance the porosity of hydrogels. For 
example, some components (progen) can be incorporated into the starting solution that can be 
removed after the hydrogel formation, in order to create a construct with tuned pore size and 
distribution. Li et al. reported that D-mannitol crystals were mixed with photocrosslinkable 
methacrylamide chitosan as a porogen to enhance pore size during hydrogel formation (67). 
Mahony and coworkers created a network of interconnected pores within a PEG hydrogel by 
incorporating a fibrin network that was later enzymatically degraded (65). 
(iii) Signal cues in hydrogels 
Hydrogels for brain tissue engineering should not only just be a supporting frame to transfer 
drugs or cells, they should also include biological cue to activate the cells in the host brain tissue 
and the encapsulated transplanted stem cells, guiding their proliferation, migration or 
differentiation. 
In stem cells transplantation, the cells viability is a key factor for the success of regeneration. In 
order to increase the cell viability, the cells attachment is usually the first consideration. Many 
ECM components such as laminin, fibronectin, and collagen, are the common choices to be 
physically blended with hydrogel or can be chemically conjugated to the hydrogel backbones. 
For example, laminins are known as a family of heterotrimeric large basement membrane 
proteins consisting of a α-chain, a β-chain, and a γ- chain.  Laminins mediate a variety of 
biological activities, and have been implicated in cell adhesion, cell migration, cell 
differentiation, and neurite outgrowth during brain development (68, 69).  Laminins could be 
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blended, physically absorbed and covalently conjugated to biomaterials (70). Furthermore, 
peptides, instead of whole ECM protein, have garnered much attention because of their synthesis 
process, easier than the isolation of ECM proteins, and their stable conjugating to other materials 
(71). For example, a variety of potential cell-binding sequences exist in the laminin, and 
seventeen different cell-adhesion sites have been reported in the α1, β1 and γ1 chains. Some cell 
surface proteins binding to laminin-1 have been reported as follows: a non-conserved RGD site 
in the α1 chain interacts with integrin α3β1 and α6β1; the GD-6 in the α1 chain interacts with 
α3β1; two peptides, YIGSR and LGTIPG, in the β1 chain probably interact with a 67kDa 
binding protein; peptide IKVAV in the α1 chain interacts with a 110kDa protein (72) (Fig 2.6). 
These different peptides have been reported for using in biomaterials modification for neural 
tissue engineering (10, 48, 73) 
 
Fig 2.6 Structural model of laminin and cell binding sites (72) 
Although some successes have been obtained in the past years for brain tissue regeneration, there 
are still many challenges in this field. How to integrate the building blocks of these complex 
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systems in brain which including the physical properties of hydrogels, the spatial and temporal 
control of signaling molecules, and the presentation of key ECM motifs, into modular and 
scalable platforms for clinical translation also need to be taken into consideration (46, 74).  
2.2.4 Vascularization in brain tissue engineering 
Stroke is the one of the leading cause of serious, long-term disability in the world, in which 
about 80% belong to the class of ischemic stroke. Besides the neuronal cell death during brain 
injury, also regenerative responses are also triggered in the tissue around the ischemic core area, 
including angiogenesis, vascular remodeling and neurogenesis. Migration of neuroblasts was 
induced after stroke into regions of degenerating striatum that border the SVZ and neuroblasts 
develop closely associated to vascular endothelial cells in an environment termed the 
neurovascular niche. In this neurovascular niche, newly born, immature neurons are closely 
associated with the remodeling vasculature. Neurogenesis and angiogenesis are causally linked 
during brain recovery through specific vascular growth factors and adhesion molecules (75, 76).  
Angiogenesis is defined as the generation of blood vessels from the existing vasculature through 
activation of proliferation and sprouting mechanism in adult endothelial cells, which was for a 
long time considered as the exclusive pathway for blood vessels formation in an adult organism 
(77). After Asahara discovered the so-called endothelial progenitor cells (EPCs), they assumed 
that endothelial progenitor cells are responsible for de novo formation of blood vessels in a 
process termed vasculogenesis which was also referred to as a collateral mechanism in 
neovascularization (78).  EPCs are defined by surface markers such as CD133 and CD34 (79), as 
well as other characteristics such as staining for von Willebrand factor, incorporation of 
acetylated low-density lipoprotein (80) and binding of ulex europaeus agglutinin  (81). EPC can 
be isolated from several sources, such as bone marrow, bone marrow-derived mononuclear cells, 
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human umbilical cord blood cells and human peripheral blood mononuclear cells (82). The key 
function of EPC includes forming vascular structures in pro-angiogenic matrices in vitro, as well 
as the potential to contribute to the vascularization in vivo (77). In human peripheral blood, two 
types of EPC were isolated from the mononuclear cells: early EPC and late EPC (83). Some 
synonyms of late EPC include outgrowth endothelial cells (OEC), late OEC, blood OEC and 
endothelial colony forming endothelial cells (77). 
In response to ischemia, many pathophysiologic changes occur in the brain microvasculature.  
Subsequently immediate events include the breakdown of the blood-brain barrier (BBB), with 
transudation of plasma, cytokines (84) and vascular matrix degradation (85). In the meantime, 
active angiogenesis is induced after focal cerebral ischemia (86) and many angiogenic factors are 
up-regulated (87). Moreover, the circulating EPCs are reduced in the stroke patients (88). 
Therefore, therapeutic enhancement of angiogenesis is a strategy for a series of different 
vascular-related diseases. Recently, therapeutic potential of EPCs has been highlighted in 
experimental cerebral ischemia. Some groups have demonstrated the EPC administration could 
restore the blood flow and enhance the tissue regeneration in experimental cerebral ischemia 
models. Furthermore, the EPC could secret several growth factors that enhance neuronal survival, 
neurogenesis, and vascular regeneration (89, 90).  In addition, vascular endothelial growth 
factors are  also widely used in experimental cerebral ischemia models because they can increase 
cerebral angiogenesis, but  also enhance neuroprotection and neurogenesis (86).  Although still a 
lot of questions remain unclear, these results are promising and provide initial ideas for treatment 
of the ischemic stroke by means of therapeutical relevant cells and suitable tissue engineering 
approaches. 
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2.3 Natural polymer: Silk fibroin 
Silk is generally defined as protein polymers which are spun fibers by some Insects larvae such 
as silkworms and flies, Arthropods such as spiders and scorpions, or Mollusks as mites. Silk 
proteins are usually biosynthesized in epithelial cells of these organisms and produced within 
specialized glands (91). Silks produced by silkworms are well known and used in biomedical 
applications particularly as sutures and in the textile industry because of its luster and peculiar 
mechanical properties. Although some delayed chronic inflammatory reaction to suture were 
observed (92), this biological responses could be overcome by removing the sericin, the glue-like 
proteins and by changing the protein conformation. Bombyx mori silkworm silk, the most 
common source of commercially available silk, have shown tunable mechanical properties, 
biocompatibility, and controlled biodegradability (93-96). Silk fibers are composed of a two 
filament: a structure  protein (silk fibroin) and a gummy substance that glues the two filaments 
together (silk sericin) (Fig 2.7).  The sericin coated outside of silk fibroin is a hydrophilic protein 
(~20-310kDa), which could be removed in the de-gumming process (97). 
 
 
Fig 2.7 Scanning electron micrograph of a silk filament partially degummed (data not published from lab). 
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2.3.1 Structure  
Silk fibroin filament has a diameter from 10um to 15um, which is composed of a heavy chain 
(~390kDa) and a light chain (~26kDa) at 1:1 ratio. These two chains are linked by a single 
disulfide bond (97) (Fig. 2.8) 
 
Fig 2.8 Silk fibroin filament composition  
 
The amino acid composition of Bombyx mori silk fibroin includes more than 16 amino acids 
whose ratio varies between different areas of the supramolecular structure of fibroin. The amino 
acid composition of silk fibroin from Bombyx mori consists primarily of glycine (Gly) (49.9%), 
alanine (Ala) (27.7%) and serine (Ser) (7.9%) (Table 2.1).  
Table 2.1 Amino acid composition of Bombyx mori silk fibroin analyzed by HPLC 
(data not published from lab) 
Amino Acid 
Amino acid 
composition (%) 
Glycine 49.9 
Alanine 27.7 
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Serina 7.9 
Tyrosine 5.3 
Valine 2.7 
Threonine 0.8 
Isoleucine 1.2 
Phenylalanine 0.8 
Lysine 0.3 
Aspartic Acid 1.0 
Leucine 0.6 
Arginine 0.6 
Glutamic Acid 0.9 
Proline 0.4 
Methionine 0 
Cysteine 0 
Histidine 0 
                                                        
The heavy chain of silk fibroin is composed of the 12 small hydrophilic domains (amorphous 
region) and 12 large hydrophobic domains (crystalline region). In the crystalline regions, each 
domain consists of sub-domain hexapeptides including: GAGAGS, GAGAGY, GAGAGA or 
GAGYGA in which G is glycine, A is alanine, S is serine and Y is tyrosine. These subdomains 
end with tetrapeptides such as GAAS or GAGS. In the amorphous region, they are between 42 
and 44 amino acid residues in length. All the linkers have an identical 25 amino acid residue 
(non-repetitive sequence), which is composed of charged amino acids absent in the crystalline 
regions (98).  
Some different secondary structures of silk fibroin are reported: α-helical (silk I) and β-sheet 
(silk II) structures in crystalline areas, and disordered conformation of random globules in 
amorphous areas.  The silk I structure is stabilized by intra-molecular hydrogen bonds, with the 
hydrophobic fragments displaced to the periphery (Fig 2.9a). Silk I is a water-soluble state (can 
be obtained in vitro in aqueous conditions) and easily converts to the silk II structure when 
exposed to physical stresses or heating. The β-sheet structures are asymmetrical with one side 
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occupied with hydrogen side chains from glycine and the other occupied with the methyl side 
chains from the alanines. Antiparallel β-sheets of silk fibroin are packed in the face-to-face, 
back-to-back mode (Fig 2.9b). The silk II structure is water insoluble in several solvents 
including alkaline conditions, mild acid and several chaotropes (97, 99). 
  
Fig 2.9. α-Helical structure of fibroin macromolecules in two projections (a) β-sheet structure of fibroin (b). (99) 
 
 
2.3.2 Tissue engineering application 
Silk fibroin has the great potential to be applied in tissue engineering and regenerative medicine. 
Bio-recognition ability of silk fibroin is the basic contribution to induce regeneration of various 
mammalian tissues. Two different active sequences VITTDSDGNE and NINDFDED, 
recognized by the integrin that promoting fibroblast growth, were localized in the N-terminal 
region of the heavy chain (100). Besides, silk fibroin could be processed into many different 
kinds of materials which enable its extensive application in tissue engineering and regenerative 
medicine (Fig 2.10). All these diverse kinds of materials start from the protocol to obtain 
aqueous silk fibroin solution (Fig 2.11) (101). Then, this silk fibroin solution can be prepared 
into films, sponges, fibers and gels (102-104). Depending on the procedure of processing and the 
source of silk, the silk fibroin could have different secondary conformation and molecule 
assembling, which result in different mechanical and biological functions (102). 
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Fig 2.10 Diverse material forms fabricated from silk fibroin: (a) fiber (b) gel (c) film (d) sponge. (Figures are not 
published data from lab)  
 
These different forms of silk fibroin materials are widely applied in tissue engineering:  
(i) For skin would healing, fibroin films and fibroin-alginate sponges have been reported to 
enhance skin wound healing in vivo compared to clinically used materials (105, 106). Oral 
keratinocytes also proliferate on woven fibroin meshes (107), a form that is likely to be used for 
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wound healing applications. Both studies concluded that fibroin-based materials promoted 
epithelialisation.  
(ii) For vascular tissue regeneration, sulphonated and heparinised silk fibroin films were reported 
for use as artificial blood vessels by adjusting suitable mechanical properties (108). The studies 
showed these films have good anticoagulant activity and platelet response and support 
endothelial cell spreading and proliferation. Besides, nano-fibrous and micro-fibrous silk fibroin 
nets have good compatibility with endothelial cells, maintaining their endothelial characteristics 
and functions (94). Biohybrid multilayer nanofiber composed of silk fibroin and poly(ε-
caprolactone) were prepared using double-electrospinning technique, displaying both an 
endothelial-conductive surface with anisotropic mechanical properties (109).  
(iii) In neural tissue engineering, especially in the peripheral nervous system, the dorsal root 
ganglia and schwann cells cultured on silk fibroin maintain their viability and keep their normal 
phenotype or functionality without any cytotoxic effects (110). Silk-Carbon nanotubes composite 
scaffolds were able to improve the neuron differentiation of human embryonic stem cells, which 
is applicable for efficient supporting matrices for stem cell-derived neuronal transplants (111).  
(iiii) Most of the research of silk fibroin has carried out for bone tissue engineering. Films, 
electrospun scaffolds and salt-leaching 3D-porous scaffolds are processed in bone tissue 
engineering (112-114). Some previously work showed that silk fibroin hydrogels and 
membranes/nets without pre-seeded cells have been used for guided bone regeneration (115, 
116). However, recently 3D porous silk fibroin scaffolds combined with MSCs resulted advance 
bone formation for the repair of critical-sized bone defects (117). Furthermore, the silk fibroin 
scaffold also modified with RGD to increase the cell attachment and slowdown the degradation 
in bone tissue engineering. RGD-silk scaffolds were demonstrated to be suitable for autologous 
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bone tissue engineering, probably because of their stable macroporous structure, tailorable 
mechanical properties matching those of native bone, and slow degradation (118). 
Furthermore, Silk fibroin are also applied in cartilage, cardiac, skin, spinal cord tissue 
engineering and so on (119). In the future, with the development of understanding of silk fibroin 
and optimization of processing, the silk fibroin could be more widely and successfully used in 
tissue regeneration. 
 
 
Fig 2.11 Silk fibroin aqueous solution preparation (101). 
 26 
 
2.3.3 Hydrogel 
Silk fibroin solution can be assembled into hydrogels by using different processing methods. The 
sol-gel transition can be induced by physical or chemical factors. In the presence of low pH, high 
temperatures, or high ionic strength which induce self-assembly into β-sheet-rich networks and 
concomitant hydrogelation of silk fibroin (120, 121). Usually, with an increase in silk fibroin 
concentration, temperature, concentration of additives like Ca
2+
, glycerol and poly (ethylene 
oxide), or a decrease in pH, gelation time decreases. In the gelation process, silk fibroin structure 
changed from random coil to β-sheet due to enhanced hydrophobic interactions and hydrogen 
bond formation (103, 122-124). In addition, silk fibroin hydrogel can also be prepared by genipin 
chemically crosslinking (Fig 2.12) (125). Genipin preferentially reacts with the amino acids 
lysine and arginine of certain proteins. However, the silk fibroin chain contains a very low 
percentage of these amino acids (0.6% for both), mainly in the hydrophilic blocks. Therefore, the 
kinetic of gelation is a slow process because the existed cross-linking sites are few in the silk 
fibroin (126). In this process, genipin can also induce the β-sheet formation of silk fibroin (127, 
128).  However, the silk fibroin gelation was very slow under these physiologically stimuli and 
genipin crosslinking, which were more suitable for 2D in vitro study of cells behavior instead of 
3D encapsulation system. Recently, relatively new protocols have been explored to induce the 
gelation of silk fibroin, such as using sonication (129) or votex (130) in which the hydrogelation 
kinetics could be easily manipulated by changing the sonication and vortex time, assembly 
temperature and protein concentration, suggesting proper techniques of 3D silk fibroin for cells 
encapsulation. This method makes it possible for new tissue engineering applications in 3D 
hydrogel constructs without harsh solution conditions that may be detrimental to cell behavior 
(129). 
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Fig 2.12 The mechanism of genipin crosslinking silk fibroin by reacting with the primary amino acid group (125). 
 
2.4 Aim of this thesis 
In order to solve the problem of brain injury caused by stroke and traumatic, brain tissue 
engineering is a promising strategy to provide appropriate biocompatible and bioactive scaffolds 
to help the damaged brain tissue regeneration. When the damaged part is large, the combination 
of stem cells is necessary to replace the lost neural cells because of the limited regeneration 
ability of the brain tissue.   
To this aim, our work is to design and evaluate an instructive injectable scaffold combined 
with stem cells for brain tissue regeneration. The stem cells (embryonic stem cells or neural 
stem cells) will be provided as cell sources to replace the lost cells in the brain damage, and 
the scaffold should induce the proliferation and neural differentiation of the implanted 
stem cells.  
To define which form of materials should be applied in brain tissue engineering, hydrogels were 
taken into prior consideration in the brain tissue engineering application as they have comparable 
physical characteristics to soft tissues. Moreover, the injectable hydrogel can avoid invasive 
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surgical procedures. Many natural polymers could be processed into hydrogels. Among these, 
silk fibroin is a natural bioactive polymer, which has been used in many different tissue 
engineering applications because of its tunable mechanical properties, biocompatibility and 
controllable degradation rates. Silk fibroin could be processed using a number of techniques to 
obtain diverse forms of materials including the hydrogel. Chemical and physical crosslinking are 
the main ways to obtain silk fibroin hydrogel. However, few studies have focused on the 
application of silk fibroin hydrogel for neural tissue engineering application, especially for brain 
tissue engineering. Therefore, we chose silk fibroin as our main material to produce hydrogels. 
Furthermore, to improve the bioactivity of hydrogel, gelatin which is the denatured collagen was 
considered to combine with silk fibroin. Different combination and crosslinking ways were 
performed to obtain hydrogels which aimed to find the optimized hydrogel for supporting stem 
cells viability and neural differentiation. Even though our final aim is to build a 3D scaffold, we 
decided to use hydrogel substrates as our starting step to choose the appropriate crosslinking and 
combination of hydrogels. Different processing of silk fibroin/gelatin hydrogel substrates were 
prepared by chemical genipin crosslinking and physical sonication crosslinking. Furthermore, 
different composition of silk fibroin and gelatin were prepared to vary structures, protein 
conformations and mechanical properties of hydrogels. Mouse embryonic stem cells (mESC) 
were used as a model to investigate the effects of these hydrogel substrates to the viability and 
neural differentiation of pluripotent cells. 
In the brain tissue engineering, a 3D hydrogel encapsulated with therapeutic stem cells, which is 
injectable, is an ideal model. Another important issue is to increase the neuron differentiation of 
stem cells in the brain tissue regeneration because neurons growth is always inhibited in the 
damaged environment with the scar formation. To achieve this aim, the physical sonication 
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crosslinked silk fibroin hydrogel was chosen from our first step and then silk fibroin hydrogel 
was produced as a 3D injectable hydrogel which allows cells encapsulation by manipulating the 
sonication parameters. To improve the neuron differentiation, silk fibroin was chemically 
modified with IKAVA peptide which derived from laminin. To evaluate the unmodified and 
IKVAV-modified hydrogels, human neural stem cell were encapsulated in both hydrogels, the 
viability and neural differentiation were then evaluated.  
The angiogenesis is also a critical aspect in the regeneration of brain tissue, especially when the 
damaged part is large. To understand whether the silk fibroin hydrogel can support the 
angiogenesis and if the conjugation of IKVAV peptide can increase angiogenesis, we prepared 
the silk fibroin unmodified and modified with IKVAV peptide, and scramble VVIAV peptide 
(control peptide). To evaluate the angiogenesis potential of different modified silk fibroin 
hydrogel, two systems were used. One is the mono-culture system in which the OEC are 
encapsulated inside hydrogels. VEGF could be added in the medium to induce the angiogenesis 
of OEC. Another system is to co-culture OEC with BM-MSCs. In this co-culture system, BM-
MSCs could induce the angiogenesis without additional growth factors.  By using these two 
systems, the angiogenesis structures formed inside hydrogels and the gene expression of 
different angiogenesis genes were evaluated. 
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Chapter 3: Different processing of silk fibroin-based 
hydrogel modulate the behavior of embryonic stem 
cells 
3.1 Part I: Gelatin/silk fibroin hydrogel substrates by chemical genipin 
crosslinking * 
*This part of work is based on the publication: Sun W, Incitti T, Migliaresi C, Quattrone A, Casarosa S, 
Motta A. 2014, Genipin-crosslinked gelatin–Silk fibroin hydrogels for modulating the behavior of 
pluripotent cells, Journal of Tissue Engineering and Regenerative Medicine. DOI: 10.1002/term.1868 
3.1.1 Introduction 
In stem cell-based tissue engineering, scaffolds are designed and fabricated as bioactive synthetic 
frameworks to promote interaction with host stem cells or with pre-seeded stem cells. The 
natural extracellular matrix (ECM) represents an appealing model to design bioactive scaffolds 
(13) and many reports have shown that ECM plays a critical role in modulating the behavior of 
stem cells (131). ECM mechanical properties and chemical cues can affect stem cells behavior 
by pulling cells against matrix or by interacting with cell surface integrins. Subsequently 
mechano-sensitive or integrin-mediated interactions convey these signals to intracellular 
downstream pathways that commit to specific cell differentiation fates or functions (16, 132, 
133). By mimicking the ECM, biomaterials can be utilized to fabricate bioactive scaffolds to 
stimulate stem cells proliferation and differentiation by delivering intrinsic physical properties or 
incorporated chemical cues (134). Moreover, instead of common growth factor-induced 
differentiation system on tissue culture plate (TCP) in vitro, various biomaterials are constructed 
as 2D or 3D matrices to help guiding stem cells differentiation into specific cell types (135, 136). 
The mechanical properties (16), chemical composition (137), and structure architecture (138) of 
scaffolds can all contribute to modulating the differentiation of stem cells. However so far, few 
reports have revealed the underlying mechanisms by which the scaffolds modulate the 
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differentiation of stem cells (139, 140). Therefore, looking for appropriate scaffolds to guide 
differentiation can benefit the successful application of stem cells in tissue engineering. 
Meanwhile, understanding the underlying mechanisms is becoming necessary in order to design 
more precise and adequate scaffolds. 
To specifically study how artificial scaffolds can affect the proliferation and neural 
differentiation of pluripotent cells, hydrogels are mainly used, as they display similar mechanical 
properties to those of the central nervous system ECM (46). As one of the emerging and most 
physiologically relevant scaffolds, hydrogels are widely applied for 2D adhesion and 3D 
encapsulation systems to study stem cells differentiation behaviors (141, 142). Both types of 
culture are useful to elucidate the precise signaling cues for stem cells differentiation into 
specific cell types (143). Collagen is a major protein component in connective tissue and is most 
abundant in ECM of mammals. Gelatin is the denatured form of collagen, showing very low 
antigenicity (144). Gelatin-based scaffolds have been reported for cartilage (145) and bone 
(146)tissue engineering and for peripheral nerve guide conduits (147). Silk fibroin is a promising 
natural polymer that has been used for many years in tissue engineering and regenerative 
medicine due to its impressive biocompatibility and tunable mechanical properties (97). Various 
reprocessing formats of silk fibroin (films, fibers, sponges) have been explored for stem cell-
based tissue engineering (124). Furthermore, silk fibroin-based materials have been shown to 
support cell adhesion, proliferation and osteogenic (148), chondrogenic (149) and neural 
differentiation (111). Blended scaffolds of gelatin and silk fibroin have been reported to enhance 
the degree of interconnection and to increase the surface area for cell attachment (150). Genipin, 
which is a natural crosslinker extracted from gardenia fruits (151), with very low cytotoxicity 
(152), has been used to crosslink chitosan, gelatin and other proteins containing residues with 
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primary amine groups (153, 154). Genipin-crosslinked gelatin has been successfully used for 
many biomedical applications in the past years (147, 155). However, few papers have reported 
data on the possible applications of genipin-crosslinked silk fibroin hydrogels and sonication-
induced silk fibroin hydrogel (156).  
In our research, the initial objective was to explore nature-derived hydrogels as active substrates 
to guide pluripotent cells proliferation and differentiation into the neural lineage by using mouse 
embryonic stem cells (mESCs). For this purpose, we prepared gelatin/silk fibroin hydrogels of 
different compositions and crosslinked by genipin. By changing the ratio between gelatin and 
silk fibroin, different morphologies, structures and mechanical properties of the hydrogel 
scaffolds were obtained and characterized. Neural differentiation was induced by culturing 
mESCs in Knockout Serum Replacement (KSR) supplemented medium for 15 days. This 
protocol shows that 50% of neurons are formed at day 15 on tissue culture plate (TCP) which 
was used as the control culture in our experiments (157). After seeding cells on TCP and 
hydrogel substrates, their viability and proliferation during differentiation were assessed through 
Live/Dead and DNA quantification assays. Moreover, the effects of substrates on mESCs 
differentiation were compared between hydrogel surfaces and TCP. Gene expression analyses 
were performed to analyze the differentiation fate by qRT-PCR at day 15.  
3.1.2 Materials and Methods 
3.1.2.1 Preparation of regenerated silk fibroin solution 
     Silk fibroin solutions were prepared according to the literature (101). Bombyx mori cocoons 
(Produced and kindly provided by Cooperativa Socio Lario, Como, Italy) (Fig 3.1.1) were peeled 
layer by layer. Then they were boiled for 30mins in 0.02M Na2CO3 (Merck, Germany) aqueous 
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solution to remove the sericin. After the de-gumming process, silk fibroin was cooling down by 
adding distilled water gradually. Then the obtained silk fibroin was thoroughly rinsed in distilled 
water. The dried obtained silk fibroin was dissolved in 9.3M LiBr (Sigma-Aldrich, U.S.A) 
(concentration at 20%) at 65
◦
C for 4 hours followed by dialysis against distilled water for 3 days 
using Slide-A-Lyzer dialysis cassettes (MWCO3500, Pierce, U.S.A). Then the silk fibroin 
solution after dialysis was centrifuged to remove the impurities and silk aggregates formed 
during dialysis. The final concentration of the silk fibroin solution was calculated by Nanodrop 
spectrophotometer (ND-1000). Usually, the silk fibroin concentration was about 5.4%. 
 
Fig 3.1.1 Cocoons kindly provided by Cooperativa Socio Lario, Como, Italy 
3.1.2.2 Preparation of genipin-crosslinked gelatin/silk fibroin hydrogels 
Gelatin (Type A, from porcine skin, Sigma-Aldrich, U.S.A) was prepared to 4wt % solution and 
genipin was dissolved to 2wt % solution in distilled water. The gelatin solution was blended with 
5.4wt % silk fibroin solution and 2wt % genipin solution in 37
◦
C under mild stirring. All 
solutions were sterilized by passing through 0.22um filters. The total solute concentration was 3% 
and genipin was 12% related to the total solute concentration (154). By changing the volume 
ratio between gelatin and silk fibroin solution, the final solutions were obtained in a mass ratio of 
gelatin: silk fibroin=100:0, 95:5, 80:20, 0:100 which were named G100, GS95, GS80, S100 
respectively. S100 solutions were then incubated at 37◦C for 48 hours and G100, GS95, GS80 
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solutions were incubated for 18 hours to crosslink and to obtain hydrogels. The hydrogel 
composition and crosslinking time are shown in Table 3.1.1. The appearances of the hydrogels 
were shown in Fig 3.1.2. 
Table3.1.1 The composition and crosslinking time of gelatin/silk fibroin hydrogels  
Sample 
code 
Gelatin 
Silk 
fibroin 
Total 
solute   
concen-
tration 
Genipin concentration 
(related to the total solute 
concentration) 
Crosslinking time 
G100 100 0 3% 12% 18h 
GS95 95 5 3% 12% 18h 
GS80 80 20 3% 12% 18h 
S100 0 100 3% 12% 48h 
 
 
Fig3.1.2 The appearance of the genipin-crosslinked gelatin/silk fibroin hydrogels 
3.1.2.3 Field Emission Scanning Electron Microscope (FE-SEM) characterization 
To characterize the internal microstructures of genipin-crosslinked gelatin/silk fibroin scaffolds, 
hydrogel samples were frozen in liquid nitrogen to avoid the formation of large crystals and then 
were lyophilized at -50
◦
C for 48 hours. The freeze-dried scaffolds were cut to expose the cross-
sections and were coated with gold. The samples were observed using the FE-SEM (SUPRA 
40/40VP ZEISS, Germany). 
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3.1.2.4 Fourier Transform Infrared - Attenuate Total Reflectance (FTIR-ATR) spectroscopy 
analysis 
The lyophilized uncrosslinked and crosslinked samples were analyzed in FTIR-ATR (Fourier 
Transform Infrared - Attenuate Total Reflectance, Spectrum One Perkin-Elmer, U.S.A). Spectra 
region were collected from 600 cm
-1
 to 4000cm
-1
. Spectra covering the amide I, II, III regions 
(1000–1800cm-1) were performed by Graphpad Prism 5.0 software.    
3.1.2.5 Rheological characterization of hydrogels 
The rheological characterization of hydrogel samples was performed in Anton Paar Physica 
MCR Rheometer 301 fitted with a circulating environmental system for temperature control. The 
plate was equipped with a Peltier chamber to control temperature and to reduce evaporation 
during measurement. After the hydrogels were crosslinked in a mold (diameter 30mm), they 
were transferred to the plate to perform characterization. Oscillatory shear measurements were 
performed to evaluate the storage and loss modulus of hydrogels. Frequency sweeps were 
performed to determine values of the storage and loss modulus from 0.1 Hz to 10 Hz in a 25mm 
cone plate configuration at 37
◦
C. A constant gap 0.7mm and strain 0.2% were used in the 
measurement. Triplicates of each hydrogel were tested.  
3.1.2.6 Genipin crosslinking degree and reactive genipin content test 
Ninhydrin assay was used to determine the crosslinking degree and reactive genipin content in 
crosslinked hydrogels (104). Ninhydrin can react with NH2 groups (both primary and secondary) 
of proteins, producing a purple color which is detectable by spectrophotometer at 570 nm. By 
calculating the amount of NH2 groups in the samples before and after crosslinking, the amount of 
NH2 groups participating in the crosslinking process and the reactive genipin content in 
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crosslinked samples can be calculated. The genipin-crosslinked hydrogels and the corresponded 
solutions without crosslinking were frozen at -80
◦
C overnight and then were lyophilized for 3 
days. Samples before crosslinking and after crosslinking were equally weighed. Subsequently, 
the lyophilized samples were heated in 3ml ninhydrin (Sigma-Aldrich, U.S.A) solution (0.35% 
w/v) in ethanol (<96%, Sigma-Aldrich, U.S.A) at 90
◦
C for 30mins under mild shaking. Each 
sample was made in triplicate. 3ml ninhydrin solution was treated under the same conditions as 
blank. After cooling down in cold water bath, the optical absorbance of the solution was 
measured with a microplate reader (Multiskan EX, Thermo Scientific, U.S.A) at a wavelength of 
570 nm. Glycine solutions of various known concentrations were used as standards. Therefore, 
the number of free NH2 group was calculated by the optical absorbance of the solution. 
Crosslinking degree and reactive genipin content can be calculated following the equation in 
which NH2
before
and NH2
after
 are the mole fractions of free NH2 remaining in the sample group 
before and after crosslinking, respectively. Here we assume that one genipin molecular reacts 
with two NH2 groups (158).      
Crosslinking degree (%) = 
NH2
before- NH2
after 
×100 
NH2
before 
 
Reactive genipin 
content (%) 
= 
(NH2
before-   NH2
after)×MolecularWeightgenipin ×100 
Weightsample×2 
 
3.1.2.7 Embryonic stem cell culture and in vitro neuronal differentiation 
The mouse embryonic stem cell line E14tg.2a (obtained from MMRRC, University of California, 
Davis) was maintained in self-renewal state by culturing on a 0.1% gelatin coated TCP in self-
renewal medium (MMRRC guidelines). Cells used for differentiation were between Passage 25 
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to 30 and cultured as previously described (157). Before seeding cells, different hydrogel 
solutions were prepared as described above, and 500ul of each was used to cover the surface of 
one well in a 12 well-plate. After hydrogels gelated at 37
◦
C, they were incubated in  self-renewal 
medium at 37
◦
C overnight to remove the excessive genipin. At day-1, cells were dissociated to a 
single-cell suspension and 1000 cells/cm
2 
were plated on the hydrogel surfaces and on 0.1% 
gelatin coated TCP, and cultured in self-renewal medium for one day. Then at day 0 the medium 
was changed to differentiation medium (Knockout Dulbecco Minimal Essential Medium 
supplemented with 15% KSR, 2mM L-glutamine, 100U/ml penicillin/streptomycin, and 0.1mM 
β-mercaptoethanol) and cultured until day 15. The medium was replaced every two days during 
the differentiation process.  
3.1.2.8 Cell viability and proliferation 
The viability of the cells seeded on hydrogels was investigated by Live/Dead assay. Live and 
dead cells were stained by calcein AM and propidium iodide (PI) respectively. Briefly, 
cells/hydrogels were washed with PBS and then were incubated in GMEM medium/calcein AM 
(1µmol/ml) at 37
◦
C for 15mins. Then cells were washed with PBS three times and were stained 
by GMEM medium/PI (20ng/ml) for 2mins at room temperature. After two more washes in PBS, 
they were observed by confocal microscopy (Nikon Eclipse Ti-E). To study cell proliferation, 
PicoGreen DNA assay was performed. Briefly, after washing with PBS, cells/hydrogels were 
collected and stored at -80
◦
C. Following lyophilization, samples were cut into small pieces and 
lysed in PBE buffer (10mM EDTA in PBS) supplemented with 1mg/ml Proteinase K for 48 
hours at 55
◦
C. After centrifugation at 2000rpm for 10 min, the supernatants were collected for 
the assay. The DNA content was determined fluorometrically at excitation wavelength of 485nm 
and emission wavelength of 538nm using a fluorescent plate reader (Tecan Infinite M200). 
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Triplicates of each sample were tested. The amount of DNA was calculated by interpolation 
from a standard curve prepared using lambda DNA in TE buffer over a range of concentrations. 
3.1.2.9 RNA isolation and QRT-PCR 
Total RNA was isolated by Trizol (Sigma-Aldrich, U.S.A) and Qiagen RNeasy Mini Kit (159). 
Briefly, after phase separation using Trizol and chloroform, the upper aqueous phase was 
collected and mixed with 0.5 volume of ethanol (<96%, Sigma-Aldrich, U.S.A). The solution 
was transferred to the RNeasy spin columns and RNA purified according to the manufacturer’s 
protocol. Reverse Transcription (RT)-PCR was performed using High-Capacity cDNA Reverse 
Transcription Kits (Applied Biosystems). Quantitative Real-Time (QRT)-PCR was performed in 
CFX96 Touch™ Real-Time PCR Detection System (Biorad). Three biological replicates of each 
sample and triplicate wells were performed. Sequences of specific primers and product length are 
listed in Table 3.1.2. 
Table 3.1.2 Oligonucleotides sequences and product length in QRT-PCR 
  
Oligonuc
-leotides 
Sequences(5’-3’) 
 Product   
length 
(bp) 
Oct4 Forward: 5’-TCAGCTTGGGCTAGAGAAGG-3’ 
Reverse: 5’-GGCAGAGGAAAGGATACAGC-3’ 
191 
Nanog Forward: 5’-TGCTTACAAGGGTCTGCTACTGA-3’ 
Reverse: 5’- TTGTTTGGGACTGGTAGAAGAATC-3’ 
113 
Nestin Forward: 5’-GATCGCTCAGATCCTGGAAG-3’ 
Reverse: 5’- AGAGAAGGATGTTGGGCTGA-3’ 
241 
βIIItubulin Forward: 5’- TTCTGGTGGACTTGGAACCT-3’ 
Reverse: 5’- ACTCTTTCCGCACGACATCT-3’ 
180 
NCAM Forward: 5’- AGGAGAAATCAGCGTTGGAG-3’ 
Reverse: 5’- CGATGTTGGCGTTGTAGATG-3’ 
182 
GFAP Forward: 5’-GGAGAGGGACAACTTTGCAC-3’ 
Reverse: 5’- CCAGCGATTCAACCTTTCTC-3’ 
164 
Keratin 18 Forward: 5’-TTGTCACCACCAAGTCTGCC-3’ 
Reverse: 5’- TTTGTGCCAGCTCTGACTCC-3’ 
213 
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GATA4 Forward: 5’-CACTATGGGCACAGCAGCTCC-3’ 
Reverse: 5’- TTGGAGCTGGCCTGCGATGTC-3’ 
146 
Brachyury Forward: 5’-GAACCTCGGATTCACATCGTGAGA-3’ 
Reverse: 5’- ATCAAGGAAGGCTTTAGCAAATGGG-3’ 
158 
Sox 17 Forward: 5’- GCCAAAGACGAACGCAAGCGGT-3’ 
Reverse: 5’- TCATGCGCTTCACCTGCTTG-3’ 
211 
 
3.1.2.10 statistics 
All statistics were performed using Graphpad Prism 5. In the reactive genipin content test, data 
were analyzed by one-way analysis of variance (ANOVA) with Tukey’s post-hoc analysis. In 
DNA quantification test, one-way ANOVA with Tukey’s post hoc analysis and two-way 
ANOVA with Bonferroni post hoc test were performed. In QRT-PCR, ddCt method was used to 
analyze the data. Gene expression of cells on TCP (control) was set as 1 (no error bars). Other 
target gene expressions were calculated by the fold change related to the control. One-way 
ANOVA with Tukey’s post hoc analysis was performed for gene expression analysis.   
3.1.3 Results  
3.1.3.1 Hydrogel morphology characterization by SEM  
SEM was used to examine the morphologies of freeze-dried hydrogels which are shown in Fig 
3.1.3. The G100 hydrogel formed porous structure and polygonal pores, with size ranging from 
10um to 20um (Fig 3.1.3a,b). The S100 hydrogel showed lamellar structures with small pores 
(Fig 3.1.3c,d). By adding silk fibroin to the gelatin, no significantly different structure was 
observed in blended samples GS95 (Fig 3.1.3e,f)  and GS80 (Fig 3.1.3g,h) compared to G100. 
Both GS95 and GS80 kept the porous morphology like G100. Besides, the GS80 hydrogel 
showed a slight decrease of pore size.  
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Fig3.1.3. Morphologies of genipin-crosslinked gelatin/silk fibroin hydrogels observed by SEM. (a,b) G100 (c,d) S100 
(e,f) GS95 (g,h) GS80. Each sample was shown in 10µm and 2µm scales respectively. 
 
3.1.3.2 Hydrogel protein conformation analysis by FTIR-ATR  
Protein secondary structures of uncrosslinked and crosslinked samples were determined by 
FTIR-ATR (Fig 3.1.4). The spectrum of uncrosslinked S100 (Fig 3.1.4Aa) showed bands at 
1644cm−1, 1514cm−1 and 1230cm−1 which corresponded to amide-I (1600-1690cm-1), amide-
II (1480-1575cm-1) and amide-III (1229-1301 cm-1) conformation region (160). Compared to 
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the pure silk fibroin film (amide II at 1540cm−1) (103), the amide II at 1514cm−1 of 
uncrosslinked S100 indicated some of the molecular chains changed from random coil to β-sheet 
structure, which was probably due to the lyophilization process. After genipin crosslinking, S100 
absorptions bands of amide I showed a shift from 1644cm−1 to 1621cm−1 (Fig 3.1.4Ba), 
indicating the further structure changes from random coil to β-sheet structure (161). It has been 
proven before that genipin could induce β-sheet structure formation of silk fibroin (154).  
Compared to the uncrosslinked G100 (Fig 3.1.4Ab), genipin-crosslinked G100 (Fig 3.1.4Bb) just 
showed a slightly shift in amide I and amide II region which indicated that the helical second 
structure of gelatin was not affected by genipin crosslinking, which was also reported by 
Chiono’s and Xiao’s papers (155, 156). In the crosslinked samples GS95 (Fig 3.1.4Bc), the 
amide I, II, III showed only slight variations with respect to the genipin-crosslinked G100 which 
were attributed to the low content of silk fibroin. The GS80 (Fig 3.1.4Bd) showed β-sheet 
structure formation after genipin crosslinking (amide II at 1516cm-1). 
 
Fig 3.1.4 FTIR spectra of uncrosslinked (A) and crosslinked (B) gelatin/silk fibroin scaffolds: (a) S100 (b) G100 (c) 
GS95 (d) GS80. 
 
3.1.3.3 Rheological test of hydrogels 
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Oscillatory shear measurements were performed to evaluate the storage and loss modulus of 
hydrogels. The typical moduli of microenvironment are Ebrain=0.1-1KPa, Emuscle=8-17KPa and 
Eosteoid=25-40KPa (16) (Fig 3.1.5). Fig 3.1.6 showed the storage and loss modulus of the 
hydrogel samples in dynamic frequency sweep test. The storage modulus was significantly larger 
than loss modulus and was weakly dependent on frequency over the entire range which revealed 
these materials were typically gelled. G100 showed the lowest storage modulus (819.0±144.0Pa). 
In contrast, the S100 showed the highest storage modulus (46.1±1.4KPa). The storage modulus 
of blended hydrogels GS95 and GS80 had been improved by increasing silk fibroin content, 
reflecting possible increase of the intermolecular bonds and also the presence of higher amounts 
of crystalline β-sheet structures in the higher silk fibroin content hydrogels. The G100, GS95, 
GS80 hydrogel dynamic storage moduli were close to the elastic modulus of brain tissue. 
 
Fig 3.1.5 Characterization of storage and loss modulus of genipin-crosslinked gelatin/silk fibroin hydrogels by 
oscillatory shear measurements during frequency sweep analysis from 0.1Hz to 10Hz. Error bars represent Mean ± 
SEM (N=3). 
 
3.1.3.4 Genipin crosslinking degree and reactive genipin content assay 
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To evaluate the crosslinking degree and reactive genipin content, ninhydrin assay was performed. 
Crosslinking degree is the relative crosslinking efficiency in each kind of sample. The G100, 
GS95, GS80, S100 showed the crosslink degree 70.1±2.1%, 61.3±2.7%, 62.6±2.5% and 
93.7±0.8% respectively (Table 3.1.3). In the hydrogel formation process by genipin crosslinking, 
genipin preferentially reacts with the amino acids lysine and arginine of certain proteins. Gelatin 
contains high percentage of theses amino acids while silk fibroin chains contain a very low 
percentage of these amino acids (154). So the S100 hydrogel formation was a slow process and 
high crosslinking degree was needed to obtain the hydrogel. On the other hand, the G100, GS95, 
GS80 samples which had high gelatin content were able to form hydrogels in shorter time and at 
lower crosslinking degree.  
In the meantime, the reactive genipin content of each crosslinked samples were shown in (Fig 
3.1.6). The G100 (***p<0.001), GS95 (**p<0.01), GS80 (***p<0.001) showed significantly 
higher reactive genipin content than pure S100 which was due to the high percentage of reactive 
sites with genipin in gelatin. Besides, GS95 showed lower reactive genipin content than G100 
(
#
p<0.05) because of the addition of silk fibroin, while GS80 showed similar reactive genipin 
content with G100 (p>0.05). 
Table3.1.3 The crosslinking degree of genipin-crosslinked gelatin/silk fibroin hydrogels 
Sample code G100 GS95 GS80 S100 
Crosslinking degree 
(% ) 
70.1±2.1% 61.3±2.7% 62.6±2.5% 93.7±0.8% 
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Fig 3.1.6 Reactive genipin content assay of Group A gelatin/silk fibroin hydrogels according to the amount of NH2 
groups which have participated the crosslinking reaction with genipin. (**p<0.01, ***p<0.001 correspond to S100, 
#
p<0.05 corresponds to G100). Error bars represent Mean ± SEM (N=3). 
3.1.3.5 Genipin-crosslinked gelatin/silk fibroin hydrogel maintain the viability and proliferation 
of ESCs   
Cell viability was assessed by confocal microscopy using calcein AM/PI staining (Fig 3.1.7A). 
At day 0, cells showed good initial adhesion on all hydrogel substrates as cells on TCP. 
Subsequently cells survived and constantly proliferated on all the hydrogel substrates throughout 
the entire differentiation protocol, with very few dead cells observed in all conditions. In order to 
precisely evaluate the proliferation rate at different time points, cells proliferation was quantified 
by analyzing the DNA content at day 0, 3, 5, 7, 15 (Fig 3.1.7B). At day 0, the cells on all 
hydrogel substrates showed lower DNA content than TCP (
###
p<0.001). This was probably due 
to the fact that the cells started to proliferate at day 0 on TCP but not on the hydrogels, according 
to the observations made by confocal microscopy.  However, cells on S100 showed better 
adhesion (
$$$
p<0.001) than on other hydrogels. At the initial stage from day 0 to day 5, the cells 
on all the hydrogel substrates showed lower proliferation speed and lower DNA content than 
TCP (
###
p<0.001). However, from day 5 to day 7, trends changed as cells on all hydrogels 
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exhibited a significant increase in proliferation (*p<0.05, ***p<0.001). At day 7, there were no 
significant differences (p>0.05) of DNA content between the cells on TCP and on hydrogel 
substrates. Moreover, the GS95 and GS80 showed higher DNA content than S100 (
$
p<0.05). 
From day 7 to day 15, cells on S100 were observed rapidly growing (***p<0.001). At day 15, 
the DNA content of cells cultured on the hydrogel substrates G100, GS95, GS80 showed no 
significant differences with TCP (p>0.05) while that on S100 showed higher DNA content 
(
##
p<0.01).  These results were confirmed by confocal microscopy observations. Therefore, both 
gelatin and silk fibroin were compatible to promote ESCs growth and proliferation. At early 
stages (from day 0 to day 7), the high gelatin content in hydrogel promoted cells proliferation 
compared to silk fibroin. However, the silk fibroin played an important role in long term cell 
proliferation (from day 7 to day 15).  
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Fig3.1.7. (A) The viability of ESCs on gelatin/silk fibroin hydrogel substrates was observed by Live (green)/Dead (red) 
assay with confocal microscopy. Bar length: 100um (B) ESCs proliferation assessed by DNA quantification. Error 
bars represent Mean ± SEM (N=3).(*p<0.05, **p<0.01, ***p<0.001. 
##
p<0.01 
###
p<0.001 correspond to TCP at the 
same time point, 
$
p<0.05, 
$$$
p<0.001 correspond to S100 at the same time point). 
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3.1.3.6 Genipin-crosslinked gelatin/silk fibroin hydrogels inhibit neural ectodermal 
differentiation of ESCs. 
Our research goal was to evaluate whether these genipin-crosslinked gelatin/silk fibroin hydrogel 
substrates could support and guide ESCs neural differentiation by comparison with TCP. To 
evaluate this, ESCs were induced to neural differentiation in KSR supplemented medium on TCP 
and on different hydrogel substrates for 15 days. The morphologies of differentiating cells were 
shown by optical microscopy pictures (Fig 3.1.8A). In this differentiation protocol, mESCs were 
seeded at a very low density, allowing isolated single cell. The single cell started to proliferate to 
form a colony and then the progeny spread around it. At day 7, cells on G100, G95 and G80 
formed colonies and also spread around them as cells on TCP, while the cells proliferated slower 
and just few cells spread around colonies on S100. At day 15, most cells on TCP showed typical 
morphology of differentiated neural cells (Fico et al., 2008). On the contrary, the cells grown on 
the hydrogel surfaces showed no obvious neural morphologies. To characterize the extent of 
neural differentiation, cells were collected at day 15 and RNA was extracted. Quantitative RT-
PCR was performed to analyze different pluripotent and neural lineage gene markers. Oct4 and 
Nanog are crucial transcription factors necessary for efficient maintenance of ESCs pluripotency 
(162, 163). At day 15, though Nanog expression levels in cells on the four hydrogel surfaces 
were similar (p>0.05) to undifferentiated ESCs, Oct4 expression levels greatly decreased 
(
##
p<0.01,
###
p<0.001). These expression profiles indicated that cells on hydrogel substrates and 
TCP were not capable to maintain pluripotency (Fig 3.1.8B). In order to characterize neural 
differentiation, the expression levels of mRNA for the neural precusor marker Nestin, the early 
neuronal marker βIII-tubulin, the late neuronal marker NCAM, and the glial marker GFAP were 
analyzed (Figure 3.1.8C). Cells on TCP showed highest expression levels of these four neural 
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differentiation markers which were consistent with the neural morphologies in the microscopy 
pictures. However, compared to TCP, cells on G100 and S100 showed greatly decreased 
expression levels of these neural markers (*p<0.05, ***p<0.001). Besides, GS95 and GS80 
showed very low expression of neural markers (**p<0.01, ***p<0.001). These results indicated 
that GS95 and GS80 could totally block neural differentiation while G100 and S100 could inhibit 
neural differentiation to a certain extent.  
3.1.3.7 Genipin-crosslinked gelatin/silk fibroin hydrogels GS95 and GS80 enhance epithelial 
ectodermal differentiation of ESCs. 
Since neural ectodermal differentiation was inhibited on these hydrogel substrates, we checked 
the expression of all three germ layer genes in order to evaluate how ESCs differentiated (Fig 
3.1.8D). Surprisingly, compared to both TCP and undifferentiated ESCs, differentiated cells on 
GS95 and GS80 showed significantly higher expression (*p<0.05, 
##
p<0.01) of Keratin18, a 
marker of epithelial ectodermal differentiation. Furthermore, cells on G100, GS95, GS80 
hydrogel substrates showed similar expression levels of Brachyury (mesodermal marker), 
GATA4 (meso-endodermal marker) and Sox17 (endodermal marker) compared to 
undifferentiated ESCs (p>0.05). However, cells on S100 exhibited higher expression of GATA4 
and Sox17 compared to both TCP and undifferentiated ESCs (*p<0.05, **p<0.01, 
##
p<0.01, 
###
p<0.001). These results indicated that cells on S100 underwent uncertain differentiation events, 
giving rise to fates from all three germ layers. However, GS95 and GS80 could guide ESCs to 
epithelial ectodermal differentiation instead of neural ectodermal differentiation.  
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Fig 3.1.8. Optical Microscopy pictures and QRT-PCR of cells on TCP, G100, GS95, GS80, S100 and of 
undifferentiated ESCs (ES) at day 15: (A) Optical Microscopy pictures of cell morphologies at day7 and day15 (B) 
Expression levels of pluripotent gene markers of ESCs: Oct4, Nanog. (C) Expression levels of neural lineage markers: 
Nestin, βIII-tubulin, NCAM, GFAP. (D) Expression levels of three germ layer genes markers: Keratin 18, Brachyury, 
GATA4, Sox17. (*p<0.05, **p<0.01, ***p<0.001 correspond to TCP, 
#
p<0.05, 
##
p<0.01, 
###
p<0.001 corresponds to ES, 
$
P<0.05, 
$$
p<0.01 correspond to S100). Error bars represent Mean ± SEM (N=3). 
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3.1.4 Discussion 
Stem cells give promising hope in the tissue engineering and regenerative medicine field because 
of their unlimited self-renewal capabilities and multilineage differentiation potential. However, 
one of the major concerns of stem cells is how to control their differentiation fates (35). In vivo, 
differentiating cells are embedded in ECM which not only provides structure support but also 
gives a dynamic environment  to modulate their proliferation and differentiation (164). Therefore, 
to overcome this limitation when differentiating stem cells in vitro, biomaterials are designed to 
construct an artificial matrix in order to guide stem cells differentiation (143). However so far, 
no efficient general principles are known to predict how stem cells behave on a given biomaterial 
(165). Therefore, some stem cell researches focused on reconstructing 2D and 3D differentiation 
matrices prepared from natural and synthetic materials to study stem cells differentiation in 
vitro(143). In this study, mESCs were used as a model to study particularly how hydrogels 
influence their behaviors. We prepared different hydrogel substrates composed of gelatin and 
silk fibroin crosslinked by genipin to evaluate their influences on the proliferation and neural 
differentiation of mESCs. Gelatin, the denatured collagen, was chosen as main component of 
hydrogel because collagen is the abundant component of all ECM in animals. Moreover, gelatin 
is a commonly referenced addition for tissue engineering of brain and spinal cord to improve the 
biocompatibility and cell attachment (166).  To increase the scaffold bioactive interaction with 
cells, silk fibroin was conjugated into the hydrogel (150, 167). To investigate the influence of 
chemical compositions and mechanical properties towards neural differentiation, we prepared 
different hydrogels with different ratios of gelatin and silk fibroin crosslinked by genipin. Since 
genipin preferentially reacts with gelatin, the gelation time of gelatin is much faster than silk 
fibroin. When the silk fibroin concentration was higher than 40% in the hydrogel, we observed 
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the phase separation under the microscopy. In order to reduce phase separation, we kept silk 
fibroin at a low content in the blended samples GS95 and GS80. By adding the silk fibroin to 
gelatin, the hydrogel morphologies slightly changed and the storage modulus was improved. In 
the crosslinking degree and reactive genipin content test, the GS95 showed lower reactive 
genipin content than G100, which was likely due to the molecular interaction between gelatin 
and silk fibroin. Through this interaction, the silk fibroin could hide some sites of gelatin to react 
with genipin. While in the GS80, some silk fibroin probably formed aggregates inside gelatin 
macromers during sol-gel transition, resulting from the phase separation. However, this phase 
separation was not visible in the microscopy. Therefore, there were comparable reactive sites 
with genipin compared to G100 which resulted in the similar reactive genipin content. When 
used to culture mESCs, the pure and blended gelatin/silk fibroin hydrogels were shown to 
maintain their viability and proliferation. In the early stage (from day 0 to day 7) of the 
differentiation process, the cells on G100, GS95 and GS80 showed higher proliferation speed 
and better cell spreading than S100. This was probably due to the larger pore size of G100, GS85 
and GS95 that could increase the cell proliferation and spread. Moreover, silk fibroin has been 
reported to play important roles in long term cells proliferation (168). In addition, ESCs seeded 
on GS95 and GS80 hydrogel substrates displayed unexpected epithelial ectodermal 
differentiation fate instead of the neural ectodermal fate that cells showed on TCP using the same 
differentiation conditions (157). Although the storage moduli of G100, GS95 and GS80 were 
close to elastic modulus of brain tissue, neural differentiation was blocked on the hydrogels. 
However, an interesting and unexpected connection was that the relatively high reactive genipin 
content in GS95 and GS80 resulted in a more efficient epithelial differentiation than cells grown 
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on S100, which had lower reactive genipin content. These results suggest that the crosslinker 
genipin could be involved in the observed epithelial ectodermal differentiation. 
In vertebrates, inhibition of the BMPs signaling pathway in the ectoderm is the hallmark of 
neural-fate acquisition, and forms the basis of the default model of neural induction. The default 
model proposes that neural induction happens as a result of the inhibition of BMPs signaling in 
the embryonic ectoderm (169). Kawasaki demonstrated that BMPs signaling was sufficient to 
block neurogenesis and to promote epithelial differentiation of mESCs (170). Interestingly, some 
papers reported that genipin was able to induce c-Jun NH2-Terminal Kinase (JNK) expression 
(171). JNK is responsible for the phosphorylation of a variety of proteins including downstream 
kinases and transcription factors such as c-Jun. Other studies showed that in Xenopus embryos c-
Jun could strongly activate BMP-4 transcription (172). 
Consequently, due to the higher reactive genipin content, GS95 and GS80 may activate the 
BMP-4 signaling pathway in mESCs, resulting in increased epithelial ectodermal differentiation 
as compared to S100. Moreover, although the GS95 and GS80 had lower reactive genipin 
content than G100, cells on GS95 and GS80 showed higher k18 (epithelial differentiation marker) 
expression and further inhibited expression of neural differentiation markers. This could result 
from the addition of silk fibroin in GS95 and GS80 increases cell interaction with the hydrogel. 
However, on the sonication-induced hydrogel surfaces without genipin, the cells went to the 
neural differentiation. Based on these data, we hypothesize that our genipin-crosslinked 
hydrogels could increase the epithelial differentiation of mESCs to an extent depending on the 
reactive genipin content and hydrogel composition. Even though the mechanical properties are 
usually important in influencing stem cells differentiation, here we suggest that the crosslinker 
genipin and the combination of gelatin and silk fibroin in hydrogels could affect stem cells 
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differentiation, shifting their fate from neural ectodermal to epithelial ectodermal without the 
participation of additional growth factors. This hypothesis needs to be further investigated. 
However, it has some implications for designing scaffold to control the ectodermal 
differentiation fate of stem cells. 
3.1.5 Conclusion 
In this study, hydrogel substrates were prepared by gelatin and silk fibroin crosslinked with 
genipin. By adding the silk fibroin to the gelatin solution, the hydrogel pore size slightly 
decreased and the storage modulus increased. In addition, the crosslinking degree and reactive 
genipin content were altered. Although S100 showed higher crosslinking degree, the G100, 
GS95 and GS80 had higher reactive genipin content than S100. Furthermore, these gelatin/silk 
fibroin hydrogels could maintain ESCs viability and proliferation. Gelatin and silk fibroin played 
important roles in short term and long term proliferation during differentiation process 
respectively. By culturing ESCs on these hydrogel substrates in KSR supplemented medium for 
15 days to induce neural differentiation, we found that the blended gelatin/silk fibroins GS95 and 
GS80 were able to change ESCs differentiation fate from neural ectodermal to epithelial 
ectodermal fate compared to TCP. 
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3.2 Part II: Silk fibroin/gelatin hydrogel substrates by physical 
sonication crosslinking 
3.2.1 Introduction 
The proliferation and differentiation of ESCs could be modulated by the culture substrates as we 
demonstrated in Part I. The structures and the chemical compositions of the hydrogel substrates 
both contribute to the proliferation and differentiation of ESCs. Interestingly, the genipin is 
suggested as a possible reason to inhibit the neural differentiation of ESC. Since our initial goal 
is to explore the hydrogel substrates for supporting the neural differentiation of ESCs. Therefore, 
the genipin crosslinking will be out of consideration in the next step.  
Besides chemical crosslinking by genipin, silk fibroin hydrogels can also be produced by 
physical crosslinking like decreasing the PH (103). However, this gelation is a relatively long 
process for the future 3D encapsulating system with therapeutic cells for brain tissue 
regeneration. Recently, the novel technique has been developed to induce silk fibroin gelation by 
sonication. The sonication is a time controllable process from minutes to hours by changing the 
sonication parameters, including power output and time, as well as the silk fibroin concentration. 
These advantages could allow the cells addition before the gelation of silk fibroin (129). 
Moreover, other different natural polymers could be added to blend with silk fibroin and 
entrapped in the hydrogel (168). 
In this study, silk fibroin hydrogel substrates were produced by sonication and physically 
blending with gelatin at different ratios. These hydrogels were characterized by FE-SEM, FTIR-
ATR and rheological test. Then mESCs were seeded on these sonication-induced hydrogel 
substrates and kept in KSR supplemented medium for 15 days as described in Part I. The 
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immunocytochemistry and QRT-PCR were performed to characterize the neural differentiation 
of  mESCs at Day 15. 
3.2.2 Materials and methods 
3.2.2.1 Preparation of regenerated silk fibroin solution 
As described in Part I. 
3.2.2.2 Preparation of sonication induced silk fibroin/gelatin hydrogels  
For sonication-induced hydrogel group, it was prepared as a total solute concentration at 2%. The 
final solution was mixed in a mass ratio of silk fibroin: gelatin= 100:0, 95:5, 80:20 which named 
S100, SG95 and SG80 (Table 3.2.1). Then these solutions were sonicated at 20% amplitude for 
20s by using sonicator Hiel scher UP400S (400W, 24kHz). The appearances of the hydrogels 
were shown in Fig 3.2.1. 
Table3.2.1 The composition and crosslinking parameter of silk fibroin/gelatin hydrogels  
Sample 
code 
Silk 
fibroin 
Gelatin 
Total 
solute   
concen-
tration 
Amplitude Sonication time 
S100 100 0 2% 20% 20s 
SG95 95 5 2% 20% 20s 
SG80 80 20 2% 20% 20s 
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Fig 3.2.1 The appearance of the sonication induced silk fibroin/gelatin hydrogels 
3.2.2.3 Field Emission Scanning Electron Microscope (FE-SEM) characterization 
As described in Part I. 
3.2.2.4 Fourier Transform Infrared - Attenuate Total Reflectance (FTIR-ATR) spectroscopy 
analysis 
The lyophilized crosslinked S100, SG95 and SG80 were analyzed in FTIR-ATR as described in 
Part I. 
3.2.2.5 Rheological characterization of hydrogels 
As described in Part I. 
3.2.2.6 Embryonic stem cell culture and in vitro neuronal differentiation 
As described in Part I. 
3.2.2.7 Immunocytochemistry  
Immunocytochemistry was performed to analyze the neural differentiation of mESCs at day 15. 
The cells/hydrogel were rinsed in PBS and fixed in 10% formalin for one hour at room 
temperature. After washing in PBS at agitation for 20 minutes, the cells/hydrogel was incubated 
in blocking solution (5%BSA + 0.1%TritonX-100 in PBS) for 2 hours. Then they were reacted 
with primary antibody for 2 hours at room temperature and overnight at 4
◦
C. After washing in 
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PBS for 45 minutes, they were reacted with secondary antibody for one hour and DAPI stainning 
for 20 mins. Primary antibodies are rabbit anti-βIII-tublin (Covance) as a neuron marker (1:1000) 
and mouse anti-MAP2 (Abcam) as a mature neuron marker (1:500). Secondary antibodies are 
Alexa Fluor 488 goat anti-mouse (Invitrogen) and Alexa Fluor 594 goat anti-rabbit (1:1000) 
(Invitrogen). 
3.2.2.8   RNA isolation and QRT-PCR 
As described in Part I. 
3.1.2.9   Statistics 
All statistics were performed using Graphpad Prism 5. In QRT-PCR, ddCt method was used to 
analyze the data. Gene expression of cells on TCP (control) was set as 1 (no error bars). Other 
target gene expressions were calculated by the fold change related to the control. One-way 
ANOVA with Tukey’s post hoc analysis was performed for gene expression analysis.   
 
3.2.3 Results 
3.2.3.1 Hydrogel morphology characterization by FE-SEM 
The sonication-induced S100 (Fig 3.2.2a,b) formed typically lamellar structures with some 
interconnected fibers in FE-SEM. The distance between the lamellar structures were around 10-
20µm. By adding the gelatin in the silk fibroin, even with the low gelatin content at SG95 (Fig 
3.2.2c,d), the typical lamellar structure decreased and more fibrous structures occurred. With the 
increasing gelatin content in SG80 (Fig 3.2.2e,f), it formed more open porous structures instead 
of lamellar structures. 
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Fig 3.2.2 Morphologies of freeze-dried sonication-induced hydrogel scaffolds by FE-SEM. (a,b) S100 (c,d) SG95 (e,f) 
SG80 
 
3.2.3.2 Hydrogel protein conformation analysis by FTIR-ATR 
After sonication, the pure silk fibroin S100 showed typical β-sheet formation (bands at 1621cm−1 
and 1514 cm
−1
) (Fig 3.2.3a). Also SG95 (Fig 3.2.3b) and SG80 (Fig 3.2.3c) showed β-sheet 
formation (bands at 1621cm
−1
 and 1622cm
-1
). In addition, the SG95 and SG80 changed slightly 
at the amide II band compare with S100, because of α-helix structure of the low content of 
gelatin. 
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Fig 3.2.3 FTIR-ATR spectra of sonication-induced silk fibroin/gelatin hydrogels: (a) S100 (b) SG95 (c) SG80. 
 
3.2.3.3 Rheological characterization of hydrogels  
Fig 3.2.4 showed the storage and loss modulus of these three hydrogels in dynamic frequency 
sweep test. The storage modulus was significantly larger than loss modulus and was weakly 
dependent on frequency over the entire range which revealed these materials were typically 
gelled. The storage modulus of S100, SG95 and SG80 were 4245.0±178.7Pa, 3909.0±109.8Pa 
and 3182.0±63.1Pa respectively. The S100 had the highest storage modulus because of the 
crystalline β-sheet structures. However, the addition of gelatin reduced the storage modulus of 
blending hydrogels. 
 
Figure 3.2.4. Characterization of storage and loss modulus of sonication-induced silk fibroin/gelatin hydrogels by 
oscillatory shear measurements during frequency sweep analysis from 0.1Hz to 10Hz. Error bars represent Mean ± 
SEM (N=3). 
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3.2.3.4 Immunocytochemistry of cells on sonication-induced hydrogels  
On the sonication-induced silk fibroin/gelatin hydrogel surfaces, the cells also started to form 
colonies from single cells. Under optical microscopy, we observed the progeny from the colonies 
at day 9. Then at day15, in contrast to genipin-crosslinked gelatin/silk fibroin hydrogel substrates, 
we found typical morphologies of differentiated neural cells on the three hydrogel surfaces (Fig 
3.2.5). In order to demonstrate the neural differentiation on these hydrogel substrates, we stained 
the cells on hydrogel surfaces and on TCP by neural markers βIII-tubulin and MAP2 at Day 15. 
Fig 3.2.6 showed that cells expressed both βIII-tubulin and MAP2 on these hydrogel surfaces 
and TCP. The cells differentiated not only in the colonies center, but also formed long 
projections around the colonies. This further indicated the neural differentiation of cells on 
sonication-induced hydrogel substrates. 
 
Fig3.2.5 Cell morphologies on sonication-induced hydrogel substrates under optical microscopy at Day 15. 
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Fig3.2.6 Immunocytochemistry analysis on sonication-induced hydrogel substrates at Day 15 
 
3.2.3.5 Sonication-induced silk fibroin/gelatin hydrogel support the neural differentiation of 
mESCs  
Quantitative RT-PCR was performed to analyze different pluripotent and neural lineage gene 
markers (Fig 3.2.7). The cells on hydrogel surfaces showed similar Oct 4 and Nanog expression 
level as cells on TCP (P>0.05). However, compared to the undifferentiated ESC, they had 
significantly decreased Oct 4 and Nanog expression which indicated that these cells lost their 
pluripotency (
#
p<0.05, 
##
p<0.01). In the meantime, they also showed the comparable expression 
levels of the neural lineage marker Nestin, βIII-tubulin, NCAM (p>0.05) and decreased levels of 
GFAP (*p<0.05) compared to TCP which indicated these sonication-induced hydrogel substrates 
supported the neuronal differentiation of ESCs as TCP but decreased astrocytes differentiation. 
 62 
 
 
 
Fig3.2.7 QRT-PCR of mESCs on TCP and sonication induced hydrogel substrates S100, SG95, SG80 and on 
undifferentiated ESCs (ES) at day 15: (A) Expression levels of pluripotent gene markers of ESCs: Oct4, Nanog. (B) 
Expression levels of neural lineage markers: Nestin, βIII-tubulin, NCAM, GFAP. (*p<0.05, **p<0.01, ***p<0.001 
correspond to TCP, 
#
p<0.05, 
##
p<0.01, 
###
p<0.001 correspond to ES) Error bars represent Mean ± SEM (N=3). 
 
3.2.4 Discussion 
In the work before (part I), we found that genipin crosslinked gelatin/silk fibroin hydrogel 
substrates guide the ESCs differentiation into epithelial lineage instead of neural lineage. As we 
discussed, the genipin is possible to be one of the main issue involved in this phenomenon. 
Therefore, in part II work, the sonication physical crosslinking was used to produce the silk 
fibroin hydrogels. We chose 2% silk fibroin as a starting concentration because it had been 
demonstrated that it was a appropriate concentration for the cell adhesion and proliferation (103). 
In additon, the elastic moduli of 2% silk fibroin were close to the brain tissue although not 
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precisely in the range of brain tissue elastic moduli. Furthermore, the 2% was the lowest 
concentration which is still possible to blend with other materials and entrap them in the gelation 
process after sonication. The pure gelatin hydrogel was not used in the part of work because the 
gelatin can not be crosslinked and gelated by sonication. When blending gelatin with silk fibroin, 
gelatin should be kept at a low content (less than 20%) to be entrapped in 2% Silk fibroin. The 
gelatin chains were possibly trapped by the β-sheet crystal domains of silk fibroin, forming non-
crystalline regions together with the crystallized regions of the silk fibroin chains which forming 
the homogeneous hydrogel (168). However, when the gelatin was more than 20%, we observed 
the precipitation in the silk fibroin which probably due to that the β-sheet crystal domains were 
not enough to entrap the gelatin chains and to form the stable hydrogel.  
After seeding mESCs on the sonication-induced hydrogel surfaces, we observed the opposite 
behavior of cells on genipin-crosslinked hydrogel substrates. The cells showed typical neuron 
morphologies with long projections under the optical microscopy. In the meantime, the presence 
of neurons was demonstrated by the staining of βIII-tublin and MAP-2 on the sonication-induced 
hydrogel substrate. QRT-PCR was performed to evaluate the gene expression related to neural 
differentiation compared to TCP. The cells on the three hydrogels showed comparable 
pluripotent gene expression (Oct 4 and Nanog) with TCP. In addition, they also showed the 
comparable expression levels of Nestin, βIII-tublin and NCAM compared to TCP which 
indicated that these hydrogel substrates supported the neuron differentiation as TCP. 
Furthermore, the cells on these hydrogels all showed significantly decreased GFAP expression 
which indicated the decreased astrocytes differentiation. This was possibly because the harder 
substrates promote the glia cells differentiation (173).  However, there were no significant 
differences between the pure silk fibroin S100 with SG95 and SG80 which were physically 
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blended with gelatin. One possible reason is that the gelatin could not interact with mESCs to 
increase the neural differentiation, while another reason could be due to the gelatin releasing 
from the silk fibroin in the medium during culturing process. 
Consequently, these findings also supported our hypothesis that genipin could be possibly 
involved in guiding ESCs to epithelial differentiation. Sonication induced silk fibroin hydrogels 
could provide an interesting model to induce neural differentiation of ESCs. However, how to 
increase the neuron differentiation is still need to be further investigated. 
3.2.5 Conclusion 
Sonication-induced silk fibroin hydrogel were produced and physically blended with gelatin 
keeping at a low content. Then addition of gelatin could increase the porous structure and 
decrease the elastic moduli of silk fibroin hydrogel. By seeding ESCs on these hydrogel 
substrates, we found that ESCs went to neural differentiation as cells cultured on TCP. However, 
these hydrogel substrates have no significant difference compared to TCP in promoting neuron 
differentiation, but decreasing the astrocytes differentiation of mESC. 
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Chapter 4: Chemical modification of sonication 
induced silk fibroin hydrogels by IKVAV peptide * 
*This part of work is based on the manuscript in preparation: Sun W, Migliaresi C, Quattrone A, 
Casarosa S, Motta A. Sonication induced silk fibroin hydrogel for brain tissue engineering. 
4.1 Introduction 
Damages to adult brain tissue can be caused by physical injuries like internal stroke or traumatic 
brain injury (TBI), resulting in death of neurons, axon disruptions and glial scar formation (174-
176). However, the adult brain has the limited regenerative ability to replace the lost neurons and 
restore the tissue function in the damaged part. Neurons have a limited ability to proliferate and 
supplement the lost ones in the damaged environment that lacks neurotrophins and contains 
neuron growth inhibitors. In parallel, glial scars could further inhibit axons regeneration as a 
mechanical barrier or by producing inhibitory molecules in the injury part (175). Traditional 
treatments for these injuries rely on neuroprotective drugs to reduce further degeneration, though 
without tissue regeneration (177). Therefore, replacing the lost neurons and restoring functional 
tissues are vital to regenerate the damaged brain tissue. In this regard, neural stem cells (NSCs) 
are promising cell resources to replace the lost neurons and glial cells because they have the self-
renewal capacity and ability to differentiate into different neural cells in the adult central nervous 
system (52). Endogenous NSCs can be found the hippocampus and the subventricular zone (SVZ) 
in the adult brain (51). However, self-repair from the endogenous NSCs is very limited (178). In 
the early reports of cell transplantation alone, cells viability was quite low after a few days after 
transplantation and the cells preferentially differentiated into glial cells. Therefore, how to 
increase cell survival and neuronal differentiation in the damaged inhibitory environment is still 
an obstacle. In brain tissue engineering, creating bioactive scaffolds combined with NSCs for 
transplantation therapy is an promising approach to regenerate tissue lost after brain injuries (58). 
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Hydrogels are attractive matrices to replace the damaged environment in stem cells 
transplantation for brain tissue engineering because of their mechanical properties comparable 
with brain tissue (46, 166). Especially injectable hydrogels, which can avoid further damage 
during the surgery procedures (179). Many hydrogel based scaffolds for brain tissue engineering 
have been reported as cell carriers or growth factor delivery vehicles (58).  For this purpose, cell 
encapsulation in a hydrogel scaffold is believed to be a promising therapeutic approach (23). 
Encapsulation involves isolating a cell mass physically from an outside environment, aiming at 
maintaining normal cellular physiology within a desired permeability barrier (180). Then the 
encapsulated cells in the hydrogel scaffold can be cultured in vitro or transplanted in vivo.  
In this study we explored the characteristics of a silk fibroin-based injectable hydrogel 
encapsulated with human neural stem cells (hNSC) as a potential strategy for brain tissue 
engineering. Silk fibroin is a natural fibrous polymer with low antigenicity and low inflammatory 
response (97). It has been used in many stem cells-based tissue engineering approaches, such as 
in bone and cartilage tissue regeneration (129, 181). Sonication is an efficient and time 
controllable way to gelate silk fibroin, which is a promising way to produce injectable hydrogels. 
Sonication initiates the formation of β-sheets structure in silk fibroin by alterations in 
hydrophobic hydration, thus accelerating the formation of physical crosslinks responsible for gel 
stabilization (129). By changing silk fibroin concentration and sonication parameters, such as 
power output and time, the gelation time could be controlled from minutes to hours. This fast 
sol-gel process allowed the addition of cells post-sonication as well as the injection into the 
target tissue before gelation. 
In order to improve the bioactivity of silk fibroin with NSCs, silk fibroin was chemically 
immobilized with the laminin-derived peptide isoleucine-lysine-valine-alanine-valine (IKVAV). 
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Laminin is one of the important components of ECM and a basement membrane glycoprotein 
(182) which promotes neural stem cells growth by coating or in the medium (183), as well as 
promotes neuron survival and neurite outgrowth (184). IKVAV, the peptide derived from 
laminin, has been proven to be the active site of cell adhesion (185) and neurite outgrowth (186). 
Self-assembling hydrogels modified with IKVAV peptide have shown to improve the survival of 
encapsulated neural stem cells/embryonic stem cells survival and neuron differentiation (58) 
(187). Modification of silk fibroin with a cell-binding peptide has been reported (118, 188). RGD 
sequences covalently bound to silk fibroin were shown suitable in bone tissue engineering (118). 
However, to our knowledge, there are no reports about silk fibroin hydrogels potential 
application for brain tissue engineering, or for the IKVAV peptide covalently conjugated to silk 
fibroin hydrogels. 
The purpose of this study is to evaluate silk-fibroin based hydrogels as potential 3D hydrogel 
scaffolds for brain tissue engineering and to understand the effects of chemical immobilization of 
IKVAV peptide for hNSCs viability and neuronal differentiation. First, we chose the 
concentration of silk fibroin according to the elastic moduli of brain tissue. The sonication 
induced silk fibroin hydrogels, unmodified and chemically modified with IKVAV peptide were 
prepared to encapsulate the hNSCs and to evaluate the cells viability and neural differentiation. 
4.2 Materials and Method 
4.2.1 Silk fibroin preparation and chemical modification 
The unmodified silk fibroin solution was obtained as described in chapter 3 part I. For chemical 
modification, the silk fibroin was dissolved in 9.3M LiBr (dissolving concentration at 20%) at 
65
◦
C for 4 hours and was dialyzed in distilled water for one day. Then they were transfer into 
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MES buffer (0.1M MES, 0.5M NaCl, PH=6) and dialyzed for another day. Then silk fibroin-
MES concentration was taken out and the concentration was measured around 5-6%. To reactive 
the carboxyl groups in silk fibroin, silk fibroin-MES solution was diluted to 3%. 0.4g EDC and 
0.25g NHS per g silk fibroin were added into the 3% silk fibroin-MES solution. After 20mins 
reaction in mild stirring, 3.5ul β-mercaptoethanol per 1mg EDC were used to quench the EDC. 
Then 2mg IKVAV peptide per g of dry silk fibroin were added and mixed for two and half hour. 
10mM hydroxylamine was used to stop the peptide conjugation reaction. Then the solution were 
dialysis for another one day against distilled water (188) (Fig 4.1). The final solution was around 
1.5%. Unmodified silk fibroin was prepared in the same manner but without the addition of 
peptide. 
 
Fig 4.1 Silk fibroin modification with IKVAV peptide 
4.2.2 Rheological characterization of hydrogels 
As described in chapter 1. 
4.2.3 Filed Emission Scanning Electron Microscope (FE-SEM) characterization 
As described in chapter 1. 
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4.2.4 Fourier Transform Infrared - Attenuate Total Reflectance (FTIR-ATR) spectroscopy 
analysis 
As described in chapter 1. 
4.2.5Human neural stem cells culture and neural differentiation 
Human neural stem cells were obtained from Gibco/Life Technologies as a commercially 
available product (N7800-200). The cells were derived from NIH approved H9 (WA09) human 
embryonic stem cells. The cells were expanded with cell-start coating plates in complete growth 
medium, which contained DMEM/F12 medium supplemented with 2% StemPro Neural 
Supplement and 2mM GlutaMAX, bFGF (20 ng/ml), EGF (20 ng/ml). After two days culture in 
complete growth medium, neural differentiation medium (Neurobasal medium supplement with 
2% B27 serum-free supplement) was placed for 7 days and changed every two days. 
4.2.6 Sonication induced silk fibroin gelation and cells encapsulation 
The 1% unmodified, IKVAV-modified silk fibroin solutions were supplemented with 
DMEM/F12 powder and sodium bicarbonate at a concentration of 0.0135 g/mL and 0.0037 g/mL, 
respectively. Then all the solutions were filtered by 0.22um filter. 0.5ml of each solution was 
loaded in 1.5ml eppendorf tube and was sonicated with the Hielscher UP400S (400W, 24kHz) 
(Fig 4.2). Each solution was sonicated at 50% amplitude for 15 seconds. After five minutes of 
sonication, the solutions were mixed with hNSC pellet (4x10
6
cells/ml hydrogel). Then 50ul of 
each sample were aliquoted to one well of 96 well plates and gelated in 37°C for 1 hour. After 
gelation, 200ul complete growth medium were added in each well. After two days, the medium 
was changed to neural differentiation medium at day 0 and cells were kept differentiating for 7 
days by changing medium every two days. 
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Fig 4.2 Sonicator Hielscher UP400S (400W, 24kHz). 
4.2.7 Cell viability assay 
The viability of the hNSCs encapsulated in hydrogels was investigated by Live/Dead assay. Live 
and dead cells were stained by calcein AM and propidium iodide (PI) respectively. 
Cells/hydrogel were washed with PBS and then were incubated in calcein AM/PBS (2µmol/ml) 
at 37
◦
C for 30mins. Then cells were washed with PBS three times and were stained by PI/PBS 
(20ng/ml) for 5mins at 37
◦
C. After two more washes in PBS, they were observed by confocal 
microscopy (Nikon Eclipse Ti-E).  
4.2.8 Cell proliferation 
The proliferation of hNSCs in hydrogels was assessed by Alamar Blue assay on day 0, 3 and 7 
after encapsulation according to the manufacturer’s instructions. The assay was performed in 96-
well plates. 50ul of cells/hydrogel were added in each well with triplicates of each sample. Each 
well was incubated with 200ul 10% Alamar Blue reagent in culture medium for 4 hours in 
humidified, 95% air/5% CO2 atmosphere at 37°C. At the end of incubation, 100ul of the 
supernatant were then transferred to a 96-well plate and fluorescence intensity was determined 
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with a microplate reader (Tecan Infinite M200) (excitation/emission: 565 nm/595 nm). The same 
media incubated with hydrogel without cells were used as controls and their fluorescence value 
was subtracted from corresponding hydrogels encapsulated with cells. 
4.2.9 Immunocytochemistry analysis 
Immunocytochemistry was performed to analyze the neural differentiation of hNSCs at day 0 
and day 7. Primary antibodies used are mouse anti-Nestin (Abcam) as a neural precusor marker 
(1:200), rabbit anti-βIII-tublin (Covance) as a neuronal marker(1:1000), mouse anti-MAP2 
(Abcam) as a mature neuronal marker (1:500) and rabbit anti-GFAP (Abcam) as an astrocyte 
marker (1:500). Secondary antibodies used are Alexa Fluor 488 goat anti-mouse and Alexa Fluor 
594 goat anti-rabbit (Invitrogen) (1:1000). 
4.2.10 Quantification of neuron percentage and neurite outgrowth length 
Nikon Eclipse Ti-E confocal microscopy was used to capture fluorescence images. The neuron 
percentage and neurite length of these images were quantified by Columbus system 
(PerkinElmer). At least three independent pictures were taken from three different samples. 
Quantification of neurons was calculated by counting βIII-tublin positive cells and MAP-2 
positive cells and divided by DAPI-stained nuclei number. Neurite length was also normalized 
by neurons number.  
4.2.11 Statistics 
Statistics were performed using Graphpad Prism 5. In Alamar Blue assay, one-way ANOVA 
with Tukey’s post hoc analysis and two-way ANOVA with Bonferroni post hoc test were 
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performed. In the quantification of neuron percentage and neurite outgrowth, t-test was 
performed. 
4.3 Results 
4.3.1 Rheology of silk fibroin hydrogel unmodified and IKVAV-modified 
The stiffness of the silk fibroin hydrogels was characterized by the oscillatory shear 
measurements. Fig 4.3 shows the storage and loss modulus of dynamic frequency sweep tests of 
silk fibroin hydrogels unmodified and modified with IKVAV peptide. The storage modulus was 
weekly dependent on the frequency and higher than loss modulus significantly which indicated 
the formation of silk fibroin gel after sonication crosslinking. The storage modulus of IKVAV-
modified silk fibroin hydrogel (2902±96Pa) was higher than the unmodified silk fibroin hydrogel 
(1366±37Pa). In the two hydrogels, the elastic moduli of unmodified silk fibroin hydrogel were 
closer to the range of brain tissue elastic moduli (100–1000 Pa) (189). 
Fig4.3 Characterization of storage and loss modulus of ummodified and IKVAV-modifed silk fibroin hydrogel by 
oscillatory shear measurements during frequency sweep analysis from 0.1Hz to 10Hz. Error bars represent Mean ± 
SEM (N=3). 
 
4.3.2 Hydrogel morphology characterization by FE-SEM 
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The hydrogel internal structure morphologies were characterized by FE-SEM (Fig 4.4). 
Unmodified silk fibroin hydrogel formed flake-like structures with some holes inside. However, 
after peptide conjugation, the modified silk fibroin hydrogels formed an interconnected porous 
structure with the pore size ranging from 10um to 20um. 
 
Fig4.4 Morphologies of freeze-dried hydrogels observed by FE-SEM. (a,b) unmodified (c,d) IKVAV-modified silk 
fibroin hydrogel. Each sample was shown in 10µm and 2µm scales respectively. 
 
4.3.3 Hydrogel protein conformation analysis by FTIR-ATR 
FTIR-ATR was performed to monitor the protein conformation changes of the unmodified and 
IKVAV-modified hydrogels before and after sonication crosslinking.  Fig4.5 shows the FTIR 
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spectra in the special range of 1800-1000 cm
-1
. According to the previous study, the absorption 
bands observed for silk fibroin at 1655±5 cm
-1
 (amide I), 1540±5 cm
-1
 (amide II) and 1235± 5 
cm
-1
 (amide III) are assigned to the random coil structure and the absorption bands at 1625±5 
cm
−1
 (amide I), 1525±5 cm
−1
 (amide II) and 1265±5 cm
−1
 (amide III) are assigned to 
characteristic of β-sheet structure (103, 190). Before crosslinking, the unmodified and IKVAV-
modified silk fibroin showed bands at 1640-1650 cm
-1
 and 1230-1240 cm
-1
 region, which 
indicated the presence of a random coil or intermediate structure (103).  However, the amide II 
bands at 1510-1520 cm
-1
 might be due to the lyophilization process (127). After sonication 
crosslinking, the bands at amide I and amide II were shifted to the 1625±5 cm
-1
, 1525±5 cm
-1
 
range which indicated the characteristic of β-sheet structure. Furthermore, the amide III bands of  
both crosslinked samples at 1233 cm
-1
  and 1272 cm
-1
 also indicated the β-sheet structure (103). 
 
Fig 4.5 FT-IR spectra of unmodified and IKVAV-modified silk fibroin hydrogel before (A) and after (B) sonication 
crosslinking. 
 
4.3.4 Cell viability assay  
The viability of cells encapsulated in the hydrogels was assessed by confocal microscopy with 
Calcium AM/PI staining at day 0 and day 7 (Fig 4.6). After encapsulation, most of hNSCs 
cultured in complete medium for two days were viable in both hydrogels at day 0. At day 7, 
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some single cells grew to aggregates and projections from cells were observed. Cells 
encapsulated in both hydrogels showed increased cell death at day 7 compared to day 0. In the 
unmodified silk fibroin hydrogels, a large amount of the cells were dead. However, the IKVAV-
modified hydrogel showed higher cell viability and better distribution in comparison to 
unmodified silk fibroin. 
 
Fig4.6 The viability of hNSCs encapsulated in unmodified and IKVAV-modified silk fibroin hydrogels analyzed by Live 
(green)/Dead (red) assay with confocal microscopy at day 0 and day 7. Bar length: 100um 
 
4.3.5 Cell proliferation assay 
Alamar Blue assay was performed to test cells proliferation during the neural differentiation 
process. In Fig 4.7, the resulting fluorescence is proportional to the number of viable cells in the 
sample, thus proliferation of hNSCs could be assessed. At day 0, the IKVAV-modified group 
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showed higher fluorescence intensity (**p<0.01) which indicates that from day -2 to day 0, the 
cells in IKVAV-modified hydrogels proliferated faster than in the unmodified hydrogels. From 
day 0 to day 3 and from day 3 to day 7, the cells in both hydrogel groups showed significant cell 
death (***p<0.001,
###
p<0.001, 
$$$
p<0.001). However, the cells in IKVAV-modified silk fibroin 
hydrogels showed higher fluorescence intensity at each time point (**p<0.01, ***p<0.001) 
which indicates that IKVAV-modified silk fibroin hydrogels could increase the proliferation of 
cells in the differentiation process compared to the unmodified silk fibroin hydrogels. 
 
Fig 4.7 Cell proliferation of hNSCs in unmodified and IKVAV-modified silk fibroin hydrogels at different time points 
analyzed by Alamar Blue assay (*p<0.05, **p<0.01, ***p<0.001. ###p<0.001 correspond to unmodified silk fibroin at 
day 0, $$$p<0.001 correspond to IKVAV-modified silk fibroin at day 0). 
. 
4.3.6 Immunocytochemistry for neuron percentage and neurite length quantification. 
Immunocytochemistry was performed to characterize the differentiated cells in the 
differentiation process at day 0 and day 7 (Fig 4.8). At day 0, cells showed positive staining of 
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nestin, which indicated their undifferentiated state after two days in culture in the self-renewal 
medium. After one week of differentiation culture, the cells were tested with Nestin, βIII-tublin, 
MAP-2 and GFAP antibodies. In both hydrogels, the cells were induced to neural differentiation 
and showed Nestin, βIII-tublin and MAP-2 positive signals, without GFAP expression. At day 7, 
the cells encapsulated in IKVAV-modified silk fibroin hydrogel showed more βIII-tublin 
positive cells compared to unmodified silk fibroin hydrogels (Fig 4.9) which indicated that more 
early neurons were differentiated. In the meantime, more MAP-2 positive cells occurred in the 
IKVAV-modified hydrogels than in the unmodified hydrogels. Furthermore, the image 
quantification showed that βIII-tublin positive cells and MAP-2 positive cells percentage in 
IKVAV-modified silk fibroin hydrogels were significantly higher than in unmodified silk fibroin 
hydrogels, revealing that the IKVAV peptide modification could increase neuron differentiation 
and neuron maturation. However, there was no significant difference of the neurite outgrowth 
length of neurons between each other. 
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Fig4.8 Immunohistochemistry analysis of hNSCs encapsulated in unmodified and IKVAV-modified hydrogesl at Day 0 
and Day 7. Cells were stained with Nestin (green), βIII-tublin (red), MAP-2 (green), GFAP (red). Scan bar=100um. 
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Fig 4.9 Quantification of the βIII-tublin and MAP-2 positive cells percentage and neurite length. 
4.4 Discussion 
Silk fibroin, the natural polymer, has been investigated for many years because of their low 
inflammatory and low immunogenic properties (191, 192). By processing aqueous silk fibroin 
solution into various kinds of materials such as films, sponges and electrospun nets can meet the 
needs of different applications such as cartilage and bone tissue engineering. Compared to these 
applications, silk fibroin hydrogel application in soft tissue engineering has been rarely reported 
(193). Recently, sonication has been developed to assemble the silk fibroin into hydrogel in a 
controlled way. The gelation time can be controlled from minutes to hours, this fast gelation 
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process can benefit the brain tissue engineering as hydrogels can then be used as injectable 
materials. In the meantime, there are no reports about sonication-induced silk fibroin applications 
for brain regeneration yet. To our knowledge, this is the first time to modify the silk fibroin by 
IKVAV peptide and to produce the IKVAV-modified silk fibroin hydrogel by sonication. 
It is notable that the stiffness of the hydrogel is very important to neural stem cells behavior 
according to many data which show it can affect neural differentiation and neurite outgrowth. In 
this experiment, we chose the most comparable elastic moduli of the silk fibroin hydrogel at 1% 
(258±16 Pa). However, the unmodified silk fibroin hydrogel storage modulus increased in the 
modification process even without the addition of peptide. This could probably due to the 
EDC/NHS addition in the modification, which could increase the β-sheet structure in the silk 
fibroin (194), which in turn results in the stiffness increase. To increase the bioactivity of 
hydrogels to neural cells, laminin-derived IKVAV peptide was preferentially selected because its 
applications for neural tissue engineering were reported (70, 195). Therefore, we hypothesize 
that the bioactivity and interaction of silk fibroin to NSCs could be increased by chemically 
modifying with laminin-derived peptide IKVAV. 
After encapsulation, cells in IKVAV-modified hydrogels showed better cell viability and higher 
proliferation than those encapsulated in the unmodified hydrogels, as shown by the Live/Dead 
and Alamar Blue analysis. One possible explanation is that the structure of IKVAV-modified silk 
fibroin hydrogel changes after the addition of peptide, compared to unmodified SF, resulting in 
more open porous structure which could benefit the cells proliferation and migration. Another 
explanation could be the IKVAV provide adhesion sequence which resulted the increase of the 
cell adhesion and thus increased the viability. In some previous work, it has been shown that bio-
adhesive sequences such as RGD and IKVAV can increase cell attachment and growth through 
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integrin-mediated pathway (196, 197).  However, the viable cells kept decreasing in both 
hydrogels in this differentiation process. One reason could be that in the differentiation process, 
many cells would turn to the apoptosis fate, which was also observed in stem cells differentiation 
on 2D differentiation process (157). Another reason could be that the IKVAV peptide 
conjugation was not enough to support the hNSC attachment and neuronal differentiation. 
Therefore, other ECM components may be needed to add in this hydrogel system. 
In this differentiation process, the IKVAV peptide could increase neuron differentiation and the 
maturation of the neurons which was probably due to the fact that it mimics laminin structure 
supports of the neural ECM. This IKVAV peptide positively improved the neuron differentiation 
fate, thus it could potentially accelerate brain tissue regeneration. In this study, there were no 
GFAP positive cells found in the differentiation process, which could due to the fact that glial 
differentiation of hNSCs takes longer time. Sun Y et al reported that the differentiation of GFAP 
positive cells took more than one month (198). Interestingly, higher ratios of neurons occurred in 
the IKVAV-modified compared to unmodified silk fibroin hydrogel after one week 
differentiation, while the IKVAV didn’t improve the length of neurite outgrowth. This could 
probably due to the hydrogel structure limitation, the pore size may be not large enough for the 
cells migration and neurite outgrowth. It was also possibly due to the relatively low 
concentration of IKVAV. 
However, this work suggested the new potential application of IKVAV-modified silk fibroin 
hydrogel in brain tissue engineering. To further improve the hydrogels, the silk fibroin hydrogel 
pore size could be optimized and increased IKVAV peptide concentration could be used to 
increase the neuron differentiation and neurite outgrowth. Another approach could involve 
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immobilizing different kinds of peptide to the silk fibroin to further increase the cell adhesion 
and neurite outgrowth.    
4.5 Conclusion 
In this study, the silk fibroin hydrogels by sonication crosslinking were prepared for brain tissue 
regeneration. By chemically immobilizing with IKVAV peptide, the morphologies of hydrogel 
scaffolds were more porous and the stiffness increased. HNSCs could be successfully 
encapsulated in hydrogels. By inducing neural differentiation of hNSCs for one week, cells in 
IKVAV-modified silk fibroin hydrogel showed better viability, proliferation, increased neuron 
differentiation and maturation compared to cells in unmodified silk fibroin hydrogel. Therefore, 
the IKVAV-modified silk fibroin hydrogel could be possibly used as potential 3D scaffolds for 
brain tissue engineering. 
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Chapter 5: Angiogenesis evaluation in sonication 
induced silk fibroin hydrogels* 
*This part of work was performed at: Experimental Trauma Surgery, University Medical Center 
Schleswig-Holstein, Kiel 24105, Germany, under the supervision of prof. Sabine Fuchs 
5.1 Introduction 
Although significant success has been achieved by combing polymers and cells in tissue 
engineering, a particular challenge still need to be solved is the loss of tissue viability after the 
implantation of larger tissue constructs. The limit of effective diffusive transport of oxygen has 
been suggested to be only 150-200 µm (199). Thus larger implanted constructs require the 
formation of the blood vessels which mediates gas and nutrient exchange, metabolic processes, 
and waste expulsion  (200). Angiogenesis is the process of new blood vessels formation from the 
pre-existing vasculature (201) which plays an important role in wound healing and tissue repair 
(202). Vasculogenesis is the neovessel formation through the assembly of endothelial cells into a 
tube, followed by stabilization and maturation into blood vessels (203). During the 
vasculogenesis, the differentiation and functional integration of endothelial progenitor cells into 
the vasculature are induced (204). Hematopoietic stem cell populations and endothelial 
progenitor cells can increase neovascularization of tissue after ischemia and contributes to 
angiogenesis, thereby, providing a ideal therapeutic option (205). OEC (Outgrowth endothelial 
cells), also called late EPC, are defined as a specific class of endothelial cells, one type of cells 
that were isolated from the mononuclear cells fraction of human peripheral blood (83).  The key 
function of EPC includes the formation of vascular structures in pro-angiogenic matrices in vitro, 
as well as the potential to contribute to the vascularization in vivo (77). Successful 
neovascularization is a critical factor for the therapeutic outcomes in organs and tissues deprived 
of an adequate, stable vasculature. Furthermore, vascularization is critical to create complex and 
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3D bioengineered tissues. To achieve neovascularization, several strategies have been reported. 
Angiogenic growth factors such as VEGF and FGF-2 were used in the delivery systems to 
induce potent angiogenic responses. Furthermore, pre-vascularized constructs based on 
endothelial cells (ECs) or EPC integrated into scaffolds and were developed for tissue 
engineering (206, 207). This strategy would allow accelerating the vascularization process after 
the implantation. 
The process of angiogenesis is controlled by the interaction of EC with angiogenic growth 
factors such as vascular endothelial growth factor (VEGF) (208), but also the ECM is very 
important factor in the development of functional blood vessels. At the initial stage of 
angiogenesis, ECs at their normal quiescent states can be activated by VEGF inducing ECs 
proliferation and sprouting of blood vessels. As angiogenesis proceeds, ECM has essential 
functions in regulating ECs migration, invasion, proliferation, and survival by providing key 
signaling events. In addition, the activated ECs proliferate and secrete various proteases, such as 
membrane-type matrix metalloproteinases (MT-MMPs) to degrade the basement membrane and 
ECM (209). The stabilization of nascent vessels is mediated by recruitment of mural cells. 
Human mesenchymal stem cells (MSCs) have been shown to efficiently stabilize nascent blood 
vessels in vivo by differentiating into perivascular precursor cells and depositing new ECM 
proteins to promote vessel formation and maturation (210). Therefore, co-cultures of EC and 
MSC have been used as a model of studying vasculogenesis (203, 211). In addition, MSC 
provide a series of growth factors such as VEGF triggering the process of neovascularization 
(212). 
As described in the chapter 3, sonication induced silk fibroin hydrogels conjugated with IKVAV 
peptide could be a candidate 3D hydrogel for brain tissue engineering. In addition, induction of 
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angiogenesis is supposed to stimulate endogenous recovery mechanisms, including neurogenesis, 
synaptogenesis, neuronal and synaptic plasticity (213). Until now, no reports have evaluated the 
pro-angiogenic potential of the sonication-induced silk fibroin hydrogel. In addition to the role of 
the IKVAV as factor to induce neurite outgrowth, this peptide has also been reported to induce 
angiogenesis (214). 
In this study, unmodified silk fibroin hydrogels, IKVAV-modified and control peptide VVIAK-
modified hydrogels were evaluated in terms of their angiogenic potential using human OECs in a 
mono-culture system or in co-culture with human bone marrow MSC. In these different 
approaches the cells were encapsulated in 3D silk fibroin based hydrogels at the concentration of 
1million cells/ml hydrogel. The structures and morphological appearances of the three hydrogels 
as well as encapsulated cells were evaluated by FE-SEM. In addition, the endothelial and 
angiogenic response was evaluated by confocal microscopy after staining for endothelial marker 
CD31. The proliferation of cells in hydrogels was evaluated by DNA quantification. QRT-PCR 
was performed to assess the expression of angiogenesis and endothelial marker related genes. 
 
5.2 Materials and Method 
5.2.1 Silk fibroin solution preparation and chemical modification 
The silk fibroin preparation and modification were the same as described by chapter 3 part I and 
chapter 4, the H2O, IKVAV and VVIAK peptide were added in modification process as 
described in chapter 4, the samples were named unmodified, IKVAV-modified and VVIAK-
modified respectively. The final concentration of the three solutions was 1%. 
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5.2.2 Isolation and expansion of OEC 
The OEC were isolated and cultured according to protocols as described previously (215). 
Mononuclear cells were isolated from peripheral blood buffy coats. 25ml peripheral blood was 
diluted with 25ml PBS in 50ml tube. Then 35ml of this mixture that was carefully added to 15 
ml of Biocoll followed by centrifugating for 35 minutes at 400g without break, according to 
Biocoll gradient centrifugation (Fig 5.1). The mononuclear cells were cultured in endothelial cell 
growth medium-2 (EGM-2) with full supplements from the kit (10 ml FBS, 0.2 ml 
Hydrocortisone, 2 ml hFGF, 0.5 ml VEGF, 0.5 ml IFG-1, 0.5 ml ascorbic acid, 0.5 ml hEGF, 0.5 
ml Heparin), 5% FBS, and 1% penicillin/streptomycin, on collagen coated well plates. 5x10
6
 
mononuclear cells/well were seeded on 24 culture-well plates and then fed with fresh medium 
every two days. After 1 week of culture, adherent cells were collected and reseeded in a density 
of 0.5x10
6
cells/well to collect OEC. Then colonies of OEC with cobble-stone-like morphology 
appearing after 2-3 weeks in culture were trypsinized and expanded. The appearance of OEC 
was shown in Fig 5.2. 
 
 
Figure 5.1 Isolation of mononuclear cells from peripheral blood buffy coat. According http://pluriselect.com/buffy-
coat.html 
 88 
 
 
 
 
Figure 5.2 The morphology of OEC 
5.2.3 Isolation and expansion of human bone-marrow mesenchymal stem cells (BM-MSCs) 
Human BM-MSCs were isolated from bone marrow of human cancellous bone fragments of 
adult donors. Bone fragments were washed several times with phosphate buffered saline to 
collect the loosely associated cell fractions. The washing solution containing bone marrow 
residues was filtered by cell strainer and centrifuged for 10 minutes at 400g, and the cell pellet 
was re-suspended in DMEM/Ham F-12 supplemented with 20% FBS and 1% 
Penicillin/Streptomycin. Cells were seeded at a density of 2×10
6
 cells/cm
2
 on collagen-coated 
flasks (T75). MSC-like colonies appearing after 7-10 days were expanded using a splitting ratio 
of 1:3 and were cultivated in DMEM-Ham F12 supplemented with 20% FBS and 1% 
Penicillin/Streptomycin.  
5.2.4 Cells encapsulation 
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500ul of each 1% unmodified, IKVAV-modified and VVIAK-modified solutions were sonicated 
at 10% amplitude for 25s by sonicator (SONOPULS HD 2070, 70W, 20kHz). After 5 minutes, 
the cell pellets were mixed with the silk fibroin solution. Then the cells/solution were added in 8-
well chamber slides (200ul in each well for confocal microscopy), in 96-well plates (50ul in each 
well for DNA quantification), in 48-well plates (200ul in each well for RNA extraction) and in 
24 well-plate (400ul in each well on coverslip for SEM). For mono-culture, 1million OEC were 
mixed with 1ml hydrogel solution. For co-culture, half million of OEC and half million of BM-
MSC were mixed with 1ml hydrogel solution. After incubation in 37
◦
C for one hour, then EGM-
2 medium plus VEGF (50ng/ml) were added in the mono-culture system, and EGM-2 medium 
were added in co-culture system. 
5.2.5 Preparation of samples for FE-SEM 
The hydrogel samples without cells for characterization were dried by freeze-drying and critical 
point drying. Freeze-drying samples were frozen the liquid nitrogen and then were transfer to the 
freeze-drier immediately. After one day lyophilization, samples were taken out and coated with 
gold, then they were observed under FE-SEM (SUPRA 40/40VP ZEISS). The critical point 
drying samples were dehydrated with increasing concentrations of ethanol from 50% (v/v) to 100% 
(v/v) at 10% per step and 15 minutes for each step. The ethanol was then removed by a critical 
point dryer. Then they were coated with Au/Pt (80/20) and were observed under FE-SEM 
(TM300, HITACHI).  
The hydrogel samples with cells were fixed in 4% formalin and 1% glutaraldehyde mixture for 
30 minutes, followed by dehydrated with increasing concentrations of ethanol from 50% (v/v) to 
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100% (v/v) at 10% per step and 15 minutes for each step, as well as critical point drying. Then 
they were coated with Au/Pt (80/20) and were observed under FE-SEM (S4800, HITACHI). 
5.2.6 Immunofluorescence staining 
At day4 and day10 after encapsulation, the hydrogel/cell samples were fixed with 4% 
paraformaldehyde, samples were washed three times with PBS and permeabilized using 0.5% 
Triton X-100 for 20 minutes. After washing in PBS for 3 times (15 minutes each time), cells 
were incubated with the following primary antibodies CD31 (Dako, 1:50) diluted in 1% bovine 
serum albumin (BSA) in PBS for 2 hour at room temperature. After washing 3 times with PBS 
(15 minutes each time), cells were incubated with the secondary Alexa Fluor 488 goat anti-
mouse antibody (Invitrogen) diluted 1:1000 in 1% BSA in PBS for 1 hour at room temperature. 
For nuclear counterstaining, cells were treated with 4',6-diamidino-2-phenylindole (DAPI). 
Samples were then observed using Zeiss LSM 510 Meta confocal laser scanning microscope. 
5.2.7 DNA quantification 
To quantify the cells proliferation, 50ul of hydrogel/cells solution were put in one well of 96-
well plate after encapsulation, triplicate samples were prepared in three different hydrogels of 
each donor at each time point. Briefly, after washing with PBS, cells/hydrogels were collected 
and stored at -80
◦
C. Following lyophilization, the sample in each well were lysed in 250ul PBE 
buffer (10mM EDTA in PBS) supplemented with 1mg/ml Proteinase K for 24 hours at 55
◦
C. 
Then DNA quantification procedure was same as described in chapter 3 part I.  
5.2.8 RNA isolation and reverse transcription 
The RNA isolation and reverse transcription was the same as described in chapter 3 part I. 
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5.2.9 QRT-PCR 
To assess the expression of endothelial markers, as well as the expression of angiogenic factors, 
QRT-PCR was performed using Glycerin-Aldehyde-3-phosphate (GAPDH) as a internal control. 
All the primers were from QuantiTect Primer Assay-Qiagen. QRT-PCR was performed using 
Rotor Gene (Quiagen) System. Primers are listed in Table 5.1. 
Table 5.1 Primers for QRT-PCR 
Gene name Sequence Company 
CD31 
F 5’-CCGGATCTATGACTCAGGGACCAT-3’ 
Eurofins 
R 5’-GGATGGCCTCTTTCTTGTCCAG-3’ 
Gene name Primer assay name Catalogue number 
SM-Actin Hs_ACTA _1_SG QuantiTect Primer Assay QT00088102 
VE-Cadherin Hs_CDH5_1_SG QuantiTect Primer Assay QT00013244 
Integrin α5 Hs_ITGA5_1_SG QuantiTect Primer Assay QT00080871 
Integrin β1 Hs_ITGB1_1_SG QuantiTect Primer Assay QT00068124 
Collagen type IV Hs_COL4A1_1_SG QuantiTect Primer Assay       QT00005250 
MMP9 Hs_MMP9_1_SG QuantiTect Primer Assay QT00040040 
GAPDH Hs_GAPDH_1_SG QuantiTect Primer Assay QT00079247 
 
 
5.2.10 Statistics 
All statistics were performed using Graphpad Prism 5. In QRT-PCR, ddCt method was used to 
analyze the data. Gene expression of cells on TCP (control) was set as 1 (no error bars). Other 
target gene expressions were calculated by the fold change related to the control. In DNA 
quantification test, one-way ANOVA with Tukey’s post hoc analysis and two-way ANOVA with 
Bonferroni post hoc test were performed. One-way ANOVA with Tukey’s post hoc analysis was 
performed for gene expression analysis.   
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5.3 Results 
5.3.1 Hydrogel morphologies by FE-SEM  
The inner structures of these three hydrogels were examined in FE-SEM by freeze-drying and 
critical point drying (Fig 5.3). In the freeze-dried samples, unmodified silk fibroin hydrogel 
formed flake-like structure with many holes on that. The IKVAV-modified and VVIAK-
modified hydrogel formed porous and fibrous structures. In contrast, these three hydrogels 
formed condense and compact structures after critical point drying and no obvious differences 
were observed between each other.   
 
Fig 5.3 FE-SEM morphologies of silk fibroin hydrogels unmodified, IKVAV-modified and VVIAK-modified by freeze-
drying and critical point drying. 
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5.3.2 Immunofluorescence staining of mono-culture from donor 1 in silk fibroin hydrogels 
unmodified and IKVAV-modified. 
The mono-culture system were incubated in EGM-2 medium plus VEGF (50ng/ml) to induce 
angiogenesis. At different time points the cells were staining with endothelial cells marker CD31 
and detected by immunofluorescence. At day 4 after encapsulation (Fig 5.4), the OEC in both 
unmodified and IKVAV-modified showed a round shape without angiogenic elongation in the 
hydrogel. At day 10, the cells still kept the round shape which indicated that angiogenic 
structures were not formed.  
 
Fig 5.4 Immunofluorescence staining of mono-culture in unmodified and IKVAV-modified hydrogels at day 4 and day 
10. The cells were stained by the endothelial cells marker CD31 (green), bar=100um. 
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5.3.3 FE-SEM of OEC mono-culture from donor 1 in silk fibroin hydrogels unmodified and 
IKVAV-modified. 
At day 10, OEC mono-culture in silk fibroin hydrogels unmodified and IKVAV-modified was 
observed by FE-SEM (Fig 5.5). From the picture, some small round shape OECs can be found in 
the both hydrogels (Fig5.5 arrows). This morphology was consistent to the morphology we 
observed by confocal microscopy, indicating that these OEC showed a small round shape, 
however, without angiogenic elongation of cells. 
 
Fig 5.5 FE-SEM of OEC mono-culture in unmodified and IKVAV-modified hydrogels at day 10.  
 
5.3.4 Immunofluorescence staining of co-cultures from three donors of OEC in silk fibroin 
hydrogels unmodified, IKVAV-modified and VVIAK-modified. 
In the co-culture systems which were incubated in EGM-2 without VEGF stimulation, the OEC 
start to form elongated structures at day4 which indicated the angiogenesis in all three hydrogels 
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(Fig 5.6). In donor 1 and donor 2, there seemed to be more elongated CD31 positive cells 
compared to donor 3. In donor 3, more round CD31 positive cells were shown at day 4, which 
could be due to the different growth status of OEC from different donors. At day10, we observed 
the typically connected and tubular angiogenic structure for samples of donor 1 in all three 
hydrogels. However, compared to donor 1, the cells from donor 2 and donor 3 just formed some 
single located angiogenic structures in hydrogels which resulted from the different angiogenic 
activity of OEC from different donors. 
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Fig5.6 Immunofluorescence staining of co-culture from three donors of OEC staining CD31 in unmodified, IKVAV-
modified and VVIAK-modified silk fibroin hydrogels at Day 4 and Day 10. The cells were stained by the endothelial 
cells marker CD31 (green) and DAPI (blue) Bar=50um. 
5.3.5 Cell proliferation. 
DNA quantification was performed to detect the proliferation of OEC/MSC during 10 days (Fig 
5.7). DNA contents were evaluated at day 0, day 4 and day 10. At day 0, there were no 
significant differences between the different hydrogels, which indicated the equal cell number 
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encapsulated in different hydrogels. Although there was a slight decrease of the DNA content at 
day 4 and slight increase of DNA content at day 10, there were no significant differences at 
different time points in the different group. This was probably due to a comparable cell growth , 
resulting in similar DNA content at different time points. Moreover, cells in three hydrogel also 
showed comparable DNA content at each time point which revealed that the cell proliferation 
speed was similar in each kind of hydrogel. 
 
Fig 5.7 The OEC/MSC proliferation assessed by DNA quantification. Error bars represent Mean ± SEM (N=3 donors). 
5.3.6 QRT-PCR of co-culture from three donors of OEC in unmodified, IKVAV-modified and 
VVIAK-modified silk fibroin hydrogel. 
In order to compare the angiogenesis related gene expression in unmodified, IKVAV-modified 
and VVIAK-modified hydrogels, QRT-PCR was performed from three donors at day 10 (Fig 
5.8).  We analyzed the endothelial markers CD31 and vascular endothelial-cadherin (VE-
cadherin), as well as the vascular stabilization involved marker smooth muscle actin (SM-actin). 
In addition we assessed Integrin α5 and MMP9 expressions which are associated with angiogenic 
activation of endothelial cells, as well as integrin β1 expression which is related to the EC 
homing, invasion and differentiation, and the collagen type IV expression which is related to the 
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basal membrane in functional blood vessels. There are no significant differences inCD31 and 
VE-cadherin expression which indicated comparable angiogenic structures in the different 
hydrogel angiogenesis from three donors. Moreover, the similar expression at integrin α5, 
MMP9 and Integrin β1 gene revealed that the angiogenic progress including EC adhesion, 
invasion and differentiation is comparable in different hydrogels (Fig 5.6). In addition, the 
collagen type IV expression resulted from the comparable production of this matrix protein in 
these different hydrogels.  
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Fig5.8 QRT-PCR analysis of OEC/MSC co-culture from three donors of OEC. Error bars represent Mean ± SEM (N=3 
donors) 
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5.3.7FE-SEM morphologies of co-culture in silk fibroin hydrogels unmodified, IKVAV-modified 
and VVIAK modified at day 10. 
 
In order to assess the morphology of the OEC/MSC co-cultures inside the hydrogel scaffold, FE-
SEM was performed (Fig 5.9). In the different hydrogel, obvious angiogenic structures were 
observed characterized by the smooth, tubular and elongating structures. The EC appear as very 
smooth cells adhered inside the hydrogel scaffold (Fig 5.9.g arrow 1) forming tubular and 
interconnected structures (Fig 5.9.g arrow 2). From the picture, very clear angiogenesis 
structures were observed (Fig 5.9.c). Smooth and flat endothelial cells with protruding cell nuclei 
were wrapped outside the tubular structure (Fig 5.9.c arrow). At the end of the tubular 
angiogenic structures, a series of branches were found which revealed the ongoing angiogenic 
progress (Fig 5.9.e arrow). Moreover, typically vascular lumen-like structure was shown in 
picture (Fig 5.9.i arrow), which indicated the maturation of the angiogenic structure. Although 
the MSCs are difficult to distinguish, some rough cells around the angiogenesis structure or 
beneath the EC are probably the MSC or differentiated MSC acting as mural cells.  
 102 
 
 
Fig5.9 FE-SEM morphologies of OEC/MSC co-culture in the three different hydrogels at day 10. 
5.4 Discussion 
According to the chapter 4, the sonication-induced silk fibroin conjugated with IKVAV peptide 
could be a candidate hydrogel for brain tissue engineering. In this part of the thesis, we evaluated 
the potential of unmodified, IKVAV-modified and VVIAK-modified silk fibroin hydrogels to 
support the formation of angiogenic structures. Compared to chapter 4, we set up the VVIAK-
modified silk fibroin hydrogel as another control of scramble peptide, in order to confirm the 
function of IKVAV sequences.   
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The first experiment was performed in order to investigate if unmodified or IKVAV-modified 
hydrogels can induce the angiogenesis of encapsulated OEC. However, even   after the addition 
of VEGF (50ng/ml) into the EGM-2 medium, the OEC still kept the round shape inside the 
hydrogel without elongated structures. In the FE-SEM pictures of hydrogel scaffolds, hydrogels 
showed a small pore size in freeze-drying samples and very condense structures after critical 
point drying. Therefore the OEC behavior could result from the condense structure of the 
hydrogel that inhibits the cells’ moving and elongation when encapsulated inside the hydrogel. If 
the cells can not move and elongate, this could cause the cell apoptosis and death. However, 
another possibility could be that the silk fibroin unmodified and IKVAV-modified could not 
support the OEC adhesion and migration which may require other factor derived from natural 
ECM.  
Interestingly, in the co-culture system, the OEC could move and elongate to form angiogenic 
structures after 4 days.  Then after 10 days they form capillary connected tubular vascular 
structures in all three different hydrogels. In the angiogenic process, the VEGF plays an 
important role in endothelial cells survival, proliferation and migration. However, the ECM is 
another important regulator of angiogenesis. In the silk fibroin hydrogels, the condense structure 
or the surface topography possibly impedes the elongation and movement of the OEC, which 
blocks the angiogenesis. However, the addition of BM-MSC seems to reverse this effect, 
resulting in angiogenesis and the formation of capillary network formation. In the co-culture 
system, BM-MSCs secret many angiogenic factors such as (VEGF and Ang-1) (216, 217). Upon 
contact with endothelial cells, BM-MSC could also differentiate into pericytes and smooth 
muscle cells that help to stabilize the nascent vessels. Furthermore, MSC produce various ECM 
components, such as collagen type I, collagen type IV, fibronectin and laminin (218). All of 
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these factors contribute to the angiogenic activation of endothelial cells and to the maturation of 
vascular structures. In the co-culture system, no significant differences in the angiogenesis 
potential among unmodified, IKVAV-modified and VVIAK-modified hydrogels were observed. 
Nevertheless potential proangiogenic effects of the IKVAV peptide might be covered by the 
strong impact of the MSC in the co-culture system. Many diverse matrix (such as collagen type I, 
collagen type IV, fibronectin and laminin) and growth factors (such as VEGF, Ang-1) produced 
by MSC may deposit in the hydrogels that obviously increasing the angiogenesis of OEC, while 
the peptide function and contribution may be much weaker than the factors produced by MSC. In 
order to demonstrate the function of IKVAV peptide in the future, another kind of model should 
be set up based on a mono-culture system where angiogenesis in OEC could be induced by 
growth factors such as VEGF. 
Consequently, the unmodified and modified silk fibroin hydrogels both support the angiogenesis 
but also need the assistance in the angiogenic process by MSC. Silk fibroin hydrogels thus 
provide a promising model of an injectable soft hydrogel system for vascularization applications 
in the field of brain ischemia, wound healing, soft tissue regeneration, cardiovascular 
regeneration and so on. 
5.5 Conclusion 
In this study, we prepared sonication-induced unmodified, IKVAV-modified and VVIAK-
modified silk fibroin hydrogels. The OEC mono-culture in unmodified and IKVAV-modified 
failed to form angiogenic structures even after the supplementation with VEGF, which might be 
due to the dense structure of the hydrogels. However, in the co-culture system, all three different 
hydrogels could support angiogenesis even although the angiogenic ability of individual donors 
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was slightly different. However, the quantity of angiogenic structures and morphologies were 
similar in the individual donors in three different hydrogels. This was further supported by the 
semiQRT-PCR. All these hydrogels could support the formation of angiogenesis structure which 
resulted in pre-vascularization in the hydrogel but need the assistance of co-implanted MSCs or 
other cells which might penetrate into the wound healing area after the implantation. 
Acknowledgements 
We would like to thank Prof. Gorb and Joachim Oesert from the Zoology Department in Kiel 
University for the excellent help in FE-SEM. We would like to thank Prof. Andreas Tholey for 
the designing of VVIAK peptide and also thank Katrin Lange and Gabriele Nessenius for the 
technician support. 
 
 
 
 
 
 
 106 
 
6 Directions for future work 
Brain tissue engineering is still facing a series of scientific challenges although researchers have 
already achieved great success in this field. In this thesis, we performed studies focusing on the 
design and evaluation of silk fibroin based hydrogels for the encapsulation of hNSC for brain 
tissue regeneration. In addition, we assessed the encapsulation of OEC/MSC in different variants 
of silk fibroin hydrogels to induce neovascularization after ischemic brain injury. 
By using 3D silk fibroin hydrogels formed after sonication, we found that the conjugation of the 
IKVAV peptide could increase the cell viability and neuronal differentiation. These data 
indicated that the silk fibroin conjugated with IKVAV peptide could be applied as a candidate 
material for brain tissue engineering. However, although the viability and neuronal 
differentiation of human neural stem cells were improved by the silk fibroin hydrogel modified 
with IKVAV peptide, they are still far away from the needs for a successful implantation because 
of the relatively low viability and ratio of neuronal differentiation. In order to improve the hNSC 
viability and neuronal differentiation, other ECM components should be considered to be added 
to the system mimicking the ECM composition in the brain.  Besides, some growth factors (such 
as neurotrophins) are necessary to be loaded in the hydrogel, which could improve the survival, 
growth and function of neurons. 
Although OEC in mono-culture did not form angiogenic structures in silk fibroin hydrogels, they 
can form angiogenic structures with the assistance of MSC. However, potential effects by  
IKVAV peptide conjugation were probably covered by the strong angiogenic effects of MSC. In 
order to further demonstrate the IKVAV peptide function in angiogenesis, another hydrogel 
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model should be set up in which the OEC are able to form angiogenesis structure in mono-
culture under growth factor stimulation, such as VEGF. 
In brain tissue engineering, the sonication induced silk fibroin hydrogel encapsulated with OEC 
and MSC could be potentially applied in treating brain injury caused by ischemia. Moreover, 
these soft silk fibroin hydrogel encapsulated with OEC/MSC are also promising in other 
applications for tissues regeneration where neovascularization is an essential element. This could 
include dermal wound healing, myocardial ischemia or soft tissue regeneration. Although MSCs 
are able to differentiate into chondroblasts, adipocytes, neurons, glia, cardiomyocytes, or 
osteoblasts, the potential of MSC usage in cell therapy of bone defects is widely discussed at 
present. It has been demonstrated that application of MSC increased angiogenesis and 
osteogenesis in the damaged bone (219). However, for brain tissue engineering, BM-MSCs are 
not well characterized as a cell source to differentiate into neural cells or to support neural 
regeneration. To solve the problem of neural cell loss and ischemia in the brain injury, some 
interesting strategies could be investigated in the future, such as the co-culture of NSCs with 
OECs or even triple culture by adding MSC in hydrogel, aiming at restoring the functional brain 
tissue. 
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